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Abstract 
The thesis describes over-expression, purification and crystallization of three proteins 
from Staphylococcus aureus (S. aureus). S. aureus is an important human pathogen 
and methicillin-resistant S. aureus (MRSA) is a serious problem in hospitals 
nowadays. The crystal structure of 3-Methyladenine DNA glycosylase I (TAG) was 
determined by single-wavelength anomalous diffraction (SAD) method. TAG is 
responsible for DNA repair and is an essential gene for both MRSA and 
methicilin-susceptible S. aureus (MSSA). The structure was also determined in 
complex with 3-methyladenine (3-MeA) and was solved using molecular replacement 
(MR) method. An assay was carried out and the molecular basis of discrimination 
between 3-MeA and adenosine was determined. 
 
The native crystal structure of fructose 1-phosphate kinase (PFK) from S. aureus was 
determined to 2.30 Å and solved using molecular replacement method. PFK is an 
essential enzyme involved in the central metabolism of MRSA. Despite extensive 
efforts no co-complex was determined, although crystals were obtained they 
diffracted poorly. An assay which can be used to test for inhibitors has been 
developed. 
 
Mevalonate Kinase (MK) is another essential enzyme in MRSA and is a key drug 
target in the mevalonate pathway. Native data diffracting to 2.2 Å was collected. The 
structure was solved using multiple isomorphorus replacement (MIR) method. A 
citrate molecule was bound at the MK active site, arising from the crystallization 
condition. The citrate molecule indicates how substrate might bind. The protein was 
kinetically characterized. A thermodynamic analysis using fluorescence-based method 
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was carried out on each protein to investigate binding interactions of potential 
fragments and thus a drug design starting point.  
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1.1 Bacterial infections and Methicillin-resistant 
Staphylococcus aureus.  
1.1.1 Bacterial infections  
Infectious diseases are one of the leading causes of death in both developed and 
underdeveloped countries. People with depressed immune system (e.g. breast feeding 
mothers and their babies) are predisposed to staphylococcal infections, such 
infections are commonly seen in hospitals and also a main causes of death (Bovill and 
Weir 1994; McGahee and Lowy 2000). 
Staphylococci are a Gram-positive spherical bacterium that usually appears as 
“clusters resembling grapes” in electron microscope images (Song, Wachi et al. 1987; 
Peacock, de Silva et al. 2001). The bacterium is a common commensal infection of 
human beings and is usually carried in the nose or on the skin of otherwise healthy 
people (Keane and Cafferkey 1983; Berman, Schaefler et al. 1986). In 1884, two 
pigmented colony types of Staphylococci were described and both of them were 
named: Staphylococcus epidermidis and Staphylococcus aureus (Peromet, Schoutens 
et al. 1973; 1982). Over 20 species of Staphylococcus have been reported and 
described (Farr 1999), however only S. epidermidis and S. aureus normally infect  
humans (Karanas, Bogdan et al. 2000). S. epidermidis normally inhabits human skin 
while S. aureus usually found both on nasal mucosa and skin of healthy people. It also 
enters the body through wounds in the skin and cause systemic or blood infections 
(Daum 1998; Feder 2000; 2001).  
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FIGURE 1.1: Scanning electron micrograph (SEM) of S. aureus bacteria. Magnified 9560x. 
(CDC/ Janice Haney Carr/ Jeff Hageman, M.H.S.) 
S. aureus infection commonly results in skin diseases, styes, mastitis, neonatal 
infections and endocarditis (heart disease) (Lye, Leong et al. 1993; Frank, Marcinak et 
al. 2002). S. aureus is considered as a major cause of both “community-acquired” and 
“hospital-acquired” infections. Hospital-acquired refers to infections of wounds, 
surgical scars medical materials or devices such as catheters (Hone and Keane 1974; 
Okumura, Muraishi et al. 1993; Zaoutis, Toltzis et al. 2006).  
 
 
FIGURE 1.2: Typical skin diseases caused by S. aureus. (Pictures taken from inernet).  
  12 
About 20% to 25% of the population is always colonized with S. aureus on the skin or 
the nose (Karanas, Bogdan et al. 2000; Chen, Su et al. 2007). They are called 
“carriers” (when bacteria are present, but not causing any infection). A further 65% 
are intermittent carriers, and only 15% - 20% people never carry this organism 
(Peacock, de Silva et al. 2001). Some studies imply that the carriage of bacteria is one 
of the main risk factors for invasive infection (Martinez-Aguilar, Hammerman et al. 
2003; Stankovic and Mahajan 2006). Healthy individuals (non-carriers) have a low 
risk of acquiring S. aureus invasive infection. Patients who have had surgery have the 
highest infection rate (Foster 2004; Lindsay and Holden 2004).  
 
1.1.2 Methicillin-resistant Staphylococcus aureus (MRSA) 
Before mid-1940’s, death from bacteria infections were quite common, especially 
with S. aureus, which had a mortality rate up to 80% (Mitsuda 2002). Before the 
introduction of antibiotics in the 1940s, S. aureus was responsible for most hospital 
infections, primarily pneumonias (Bovill and Weir 1994; Graham 2002). At the 
beginning of the use of antibiotics (penicillin), all S. aureus infections were sensitive 
to penicillin (Panzaru, Gotia et al. 2002). However, antibiotic resistance developed in 
some S. aureus strains and other organisms within a very short time (Kanra, Caglar et 
al. 1985). As early as the 1950s, penicillin-resistant strains of S. aureus had reported 
for the first time (Rawal 1969; Song, Wachi et al. 1987). Then, methicillin (an 
analogue of synthetic penicillin) was introduced in 1959 and released onto the market 
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in 1960 used to treat penicillin-resistant S. aureus infections (Hone and Keane 1974; 
Giamarellou, Papapetropoulou et al. 1981). However, one year later, the United 
Kingdom first reported that some strains isolated from S. aureus had acquired 
resistance to this new antibiotic (Jovens, 1961). Soon methicillin-resistant S. aureus 
(MRSA) isolates were reported in other countries in Europe, then Australia, United 
States and some Asian countries (Japan and Vietnam) (Giamarellou, Papapetropoulou 
et al. 1981; Haley, Hightower et al. 1982; Boyce, White et al. 1983). By 1980, MRSA 
had spread throughout the world, and most of these MRSA strains were resistant to 
more than one antibiotic. MRSA, together with other antibiotic-resistant bacteria, 
cause over 60% of nosocomial infections in both developed and underdeveloped 
countries (Chang, Hsu et al. 1988; Farr 1999). As a result of the emergence of MRSA, 
S. aureus has re-emerged as a major health problem (Washer and Joffe 2006). MRSA 
infections now has become a significant issue and a priority task in hospitals 
worldwide (Branger, Gardye et al. 2003). 
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FIGURE 1.3: Scanning Electron Microscopy (SEM) micrograph of Methicillin-resistant S. aureus 
aureus NW15. Magnified 20, 000X. (CDC/Jim Biddle).   
Until recently, MRSA infections had been limited mainly to patients in hospitals. 
However, the rise in “community-acquired” MRSA infections has raised new 
concerns. Infections are now occurring in healthy, non-hospitalized people who lack 
physical contact with healthcare personnel or other colonized patients (Herold, 
Immergluck et al. 1998). These incidents have raised serious concerns about the 
possibility of wide spread of MRSA outside the healthcare system. If MRSA were to 
become the major form of S. aureus, the treatment of bacterial infections will be much 
more difficult and expensive (Richet, Benbachir et al. 2003). Some strains are 
resistant to most regularly used antibiotics, with even vancomycin-resistance known 
(Milatovic 1986; Walsh, Fisher et al. 1996).  
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1.2 Antibiotics resistance 
Antibiotics originally were defined as metabolites of small microbes that inhibit the 
growth or kill other microorganisms (Romano 1953; Mlynarczyk, Mlynarczyk et al. 
1979). Now they refer more generally to drugs used for the treatment of bacterial 
infections. The first antibiotic, penicillin(Patelski and Hobby 1952; Fletcher 1984), 
was discovered in 1927 by Alexander Fleming (Hughes 1952; Lachowicz 1960) and 
first used for medical treatment in 1940s (Steinman 1962; Sabath, Wheeler et al. 
1977). Penicillin changed medical care fundamentally, reduced disease and death, and 
in some cases eliminated the bacterial disease as a cause of death. Although the first 
antibiotics were natural compounds produced by other microorganisms, these were 
followed by some semi-synthetic antibiotics such as roxithromycin and clindamycin 
that derived produced by chemical modification of natural antibiotics (Kayser, Benner 
et al. 1970; Whipp 1987). Now over 10, 000 antibiotics have been characterized and 
synthesized and grouped into several different classes, and the most frequently used is 
the β-lactam class (Sieradzki, Leski et al. 2003; Kareiviene, Pavilonis et al. 2006)  
 
FIGURE 1.4: Molecular structures of penicillin-type antibiotics. β-lactam ring is shown in red. 
  16 
1.2.1 Mechanism of antibiotic resistance 
Antibiotics are natural products that evolved as a method of chemical defense to kill 
competing organisms. However, the evolution of production of these antibiotics in the 
bacterium requires co-evolution of resistance (Paulsen, Brown et al. 1996; 
Borges-Walmsley and Walmsley 2001). The term “antibiotic resistance” refers to the 
ability of bacteria to survive and grow in the presence of an antibiotic. Resistant 
bacteria thus continue to harm humans or animals during treatment.  
 
Since antibiotics target the fundamental process in bacteria (Mlynarczyk, Mlynarczyk 
et al. 1979; Higashi, Wakabayashi et al. 1999) usually leading to cell death, 
evolutionary pressure thus rapidly selects drug resistant mutants. Antibiotic resistance 
is therefore essentially unavoidable and several common resistance mechanisms have 
evolved. The four main categories of antibiotic resistance mechanisms are: 
Modification to inactivate the drug; Efflux pumps to remove drugs; Cell wall changes 
to reduce drug entry and mutation of the target to reduce the drug inhibition (Whipp 
1987; Ramage, Bachmann et al. 2002; Poole 2004). 
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FIGURE 1.5: Main mechanisms of antibiotics resistance. Antibiotics are shown in grey spheres. 
Picture taken from The Science Creative Quarterly (Wilcox, Sara, 2004).  
1.2.2 Chemical modification of the drug 
All β-lactam antibiotics have a similar mechanism; they inhibit the formation of the 
cell wall by interrupting the peptidoglycan biosynthesis. (Powledge 2004; Xiao and 
Yao 2004). The β-lactam binds to penicillin-binding proteins (PBPs) in the cell wall 
of Gram-positive and Gram-negative bacteria, inhibiting them by forming covalent 
bonds with the active site residue (serine) (Katayama, Zhang et al. 2003; Poole 2004). 
Without PBPs, the transpeptidation reaction is prevented, and the peptidoglycan 
biosynthesis halts (Spratt and Cromie 1988). The β-lactam ring is the active group of 
these β-lactam class (penicillin-type) antibiotics. The β-lactamase enzyme hydrolyzes 
the β-lactam ring moiety breaking it open. Losing the ring conformation of β-lactam, 
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means the antibiotic is then unable to bind PBPs, and no longer inhibits cell wall 
biosynthesis (Massova and Mobashery 1998).  
 
For some non β-lactam class antibiotics such as the aminoglycoside class 
(usually comprised of an amino group and a sugar group) (Crabtree, Pelletier et al. 
1999), the antibiotic is covalently modified with moieties that change its function. 
Resistant bacteria express aminoglycoside-modifying enzymes that can add additional 
groups such as PO32-, AMP or acyl group to the target, changing or reducing its 
affinity for RNA and thus its effectiveness (Shaw, Rather et al. 1993) (FIGURE 1.6).  
 
FIGURE 1.6: Chemical modification of the drug in cells.  The conformation of antibiotics were 
changed by enzymes which expressed by antibiotic resistance gene in the cell. Then the antibiotics 
lose the activity to inhibit or kill the bacteria. Picture modified from The Science Creative 
Quarterly. (Yim, 2009) 
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1.2.3 Efflux pumps  
The mechanism of efflux pumps is employed by both gram-positive and 
gram-negative bacteria. Efflux pumps can specifically recognize and pump out the 
antibiotic, lowering the concentration of the drug in the cell (Paulsen, Brown et al. 
1996). By pumping the antibiotic out of the cell at a faster rate than it can diffuse in, 
the concentration of the antibiotic is remains below the effective level (Walsh 2000). 
Most of these pumps are trans-membrane proteins that mediate the expulsion of 
antibiotics and solvents from the cell (Levy 1992). Efflux pumps are a common 
self-protection mechanism by antibiotic producers (Kaatz 2002) (FIGURE 1.7).  
 
FIGURE 1.7: Efflux pumps mechanism in the cell. The efflux pumps are consisted by several 
membrane proteins. They keep pumping out the antibiotics out of the cell that the concentrations 
of antibiotics never get high enough to have its effective. Picture modified from The Science 
Creative Quarterly. (Yim, 2009) 
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1.2.4 The cell wall impermeability 
The hydrophobic cell wall/outer membrane of bacterium cells is an important 
self-defense mechanism (Sieradzki and Tomasz 1997). The cell walls have selective 
permeability, meaning that they allow only certain molecules to pass through whilst 
stopping others. The lipid bilayer serves to slow the passage of antibiotics into the cell 
(Viriasov and Perelygin 1984; Urisu, Rahman et al. 2005). The permeability can be 
changed by expressing different proteins or altering the amount of the certain proteins 
(Asaoka, Yoshida et al. 1992; Dionne, Cain et al. 1996). In addition, recent studies 
have shown that cell wall/outer membrane impermeability often occurs in 
combination with other mechanisms such as efflux pumps, thus conferring the drug 
resistance (Gao, Laval et al. 2003). 
 
FIGURE 1.8: Cell wall/outer membrane impermeability mechanism in the cell. Picture modified 
from The Science Creative Quarterly (Yim, 2009). 
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1.2.5 Mutation of the drug target 
Antibiotics target protein structure can be modified or mutated to relieve drug 
inhibition (Spratt 1994; Walsh 2000). The basis of the methicillin resistance in S. 
aureus is the acquisition of methicillin resistance gene (mecA), this gene can encode a 
protein which is called “methicillin-resistant penicillin-binding protein”. This is an 
altered version of PBP, antibiotics such as methicillin can still bind to this PBP but 
with a much lower affinity (Song, Wachi et al. 1987; Chu, Plattner et al. 1996).  
1.2.6 Multi-drug resistance 
The spread of antibiotic resistance is driven by natural selective pressures placed on 
the bacterium by the continued use of antibiotics. It is also promoted by the 
promiscuity of gene transfer between bacteria (Levy 1998). Vancomycin was first 
introduced in 1958 and no clinical isolates of vancomycin-resistant bacteria observed 
until 29 years later (Rahman 1998). Vancomycin is still used in the clinic and is 
considered as the ultimate treatment of otherwise drug-resistant gram-positive 
bacterial infections (Lundstrom and Sobel 2000).  
29 years are actually a long time as clinically significant resistance usually appears 
within only months to a few years after the introduction of a new antibiotic (Davies 
1996), especially when it only targets one gene product. It is believed that the unusual 
time delay for vancomycin resistance is almost certainly due to the complexity of its 
resistance mechanisms, requiring the action of five gene products (Walsh, Fisher et al. 
1996) and its relatively restricted usage.  
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The development of drug resistance in bacteria occurs by two main mechanisms, 
mutation of genes in chromosome followed by resistant strains selection and 
acquisition of resistance genes by harboring mobile elements (plasmids, transposons) 
(Arthur and Courvalin 1993; Davies 1994) (transposons are DNA sequences that can 
move from one location to another location with the genome). The methicillin 
resistance gene (mecA) in MRSA is usually carried by a plasmid known as “S. aureus 
cassette chromosome mec (SCCmec)”. These plasmids replicate within the cell and 
subsequently spread to other cells, strains and even across species (Davies 1994). 
Transposons can excise themselves from one location to another, integrate into new 
location in a new bacterium, so antibiotic resistance genes encoded within transposons 
move between plasmids and genome (Tolmasky 2000; Scott 2002). Mobile genetic 
elements can accumulate more than one set of resistance genes from more than one 
organism; as a result, multi-drug resistant bacteria can emerge and transfer resistance 
to other species (Burrus, Pavlovic et al. 2002; Pembroke, MacMahon et al. 2002).  
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FIGURE 1.9: Horizontal transfer of the drug-resistant gene among bacteria. The resistant gene 
can be passed around bacteria strains by transformation, conjugation and transduction. Picture 
modified from The Science Creative Quarterly (Yim, 2009). 
1.3 Genetics and Proteomics feature of resistance on S. 
aureus 
1.3.1 MRSA252 and MSSA476 strains 
To help to better understand the pathology of these disease-causing S. aureus bacteria, 
comparison of the proteomes of these MRSA and MSSA strains was carried out by 
the lab of Dr P. Coote (University of St Andrews) to identify proteins that could be 
important to pathogenesis, such proteins could lead to the identification of new drug 
targets in MRSA.  
The genomes of the two disease-causing S. aureus strains have been sequenced and 
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annotated by The Sanger Institute Pathogen Sequencing Unit recently (Enright, Day et 
al. 2000). These two strains were clinically isolated, one strain represents the 
“hospital-acquired epidemic methicillin-resistant S. aureus (HA-EMRSA)” 
EMRSA-16 clone (MRSA252), which is found worldwide and is clinically prevalent 
lineage causing 50% MRSA infections in U.K (Johnson, Aucken et al. 2001).  
 
MRSA252 was first isolated from a female patient in 1997 after a small-scale 
outbreak in a hospital (Johnson, Aucken et al. 2001; Moore and Lindsay 2002). 
MRSA252 is known to be resistant to methicillin, penicillin, erythromycin and 
ciprofloxacin (Johnson, Aucken et al. 2001).  
 
The community-acquired MSSA476 was chosen for comparison, it can cause severe 
invasive disease in some immunocompetent children outside hospital settings. 
MSSA476 strain was isolated from a 9-year old boy in 1998 with systemic infection 
(Enright, Day et al. 2000). This strain is resistant to fusidic acid and penicillin, 
sensitive to most frequently used antibiotics, including ciprofloxacin, rifampicin, 
tetracycline, trimethoprim, erythromycin, gentamicin, amikacin, and methicillin. A 
comparative-genomics-method has been applied to S. aureus genomes to identify the 
key regions that might be responsible for virulence and antibiotic resistance (Holden, 
Feil et al. 2004).  
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FIGURE 1.10: Circular diagrams of MSSA476 and MRSA252 chromosomes. Picture taken from 
(Holden, Feil et al. 2004) 
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1.3.2 Differences between MRSA252 and MSSA476 
The MRSA252 chromosome has a size of 2,902,619 bp and contains 2,671 predicted 
protein-coding sequences (CDSs). While the MSSA476 is 2,799,802 bp in size and 
has 2,565 genes. Comparisons between these two chromosomes indicate that they are 
collinear with each other and also similar to those published S. aureus isolates such as 
MW2, Mu50, and N315 (Baba, Takeuchi et al. 2002; Feil, Cooper et al. 2003). The 
MRSA252 and MSSA476 genome sequences both have a common conserved core 
region. However their accessory genetic elements show some differences. About 6% 
of the genome is novel, including several unique genetic elements that are considered 
as critical for antibiotic resistance. Pseudogenes are known to be a regular feature of 
bacterial genomes and are found within the genomes of bacterial pathogens (Ross 
1985) in particularly high numbers. Although MSSA476 is sensitive to methicillin, it 
contains a novel Staphylococcal chromosomal cassette (SCC) mec-like element. The 
integrated site of this element is same to SCCmec in MRSA252. However, this 
genetic element encodes a different protein compared with MRSA252.  
 
 MRSA252 MSSA476 
Length of sequence (bp) 2,902,619 2,799,802 
G + C content 32.81 32.85 
CDS count 2671 2565 
Average length 896 882 
GC percentage 33.52 33.59 
tRNA 60 60 
rRNA 16 19 
5S 6 7 
16S 5 6 
23S 5 6 
Stable RNAs 25 25 
Pseudogenes 66 20 
Transposons 3 0 
SCC elemets Type II SCCmec SCC476 
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TABLE 1.1: Summary of the general features of MRSA252 and MSSA476 genomes.  
Beyond the genetic diversity, the proteomics differences of these two strains may be 
important. We therefore reasoned that the MRSA252 up-regulated proteins may be 
particular important for pathogenicity with the potential for new drug targets 
embarked on the structural characterization. 2-Dimensional sodium dodecyl sulfate - 
polyacrylamide gel electrophoresis (SDS-PAGE) techniques were employed in 
identification of the differential expression level. Gels were silver-stained and proteins 
that were expressed differentially amount between the two strains were identified by 
eye (work of Dr. P. Coote (University of St Andrews)).  
 
An initial 30 differentially expressed proteins were identified by Dr P. Coote 
(University of St-Andrews) as being significantly up regulated or down regulated. 
Then these potential targets were examined by peptide mass spectrometry (University 
of St-Andrews) by excised the target protein spots from the gels. An Investigator 
Progest Digestion Robot (Genomic Solutions) was using to perform these 
examinations. The web-based Mascot Search Engine (MSDB) 
(http://www.matrixscience.com/search_form_select.html) was used for peptide mass 
matching search.  
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FIGURE 1.11: Result sample of silver stained 2D SDS-Page gel comparison of the proteomes of S. 
aureus MRSA252 and MSSA476. 
After the identification of the potential targets, BLAST (Altschul, Madden et al. 1997) 
was used to determine that there was no protein structure deposited in the Protein 
Data Bank (PDB) with sequence homology (>70%). The sequences of the target 
proteins were assessed for suitability for structural study using some bioinformatics 
tools, such as the Regional Order Neural Network (RONN) application. RONN 
identifies disordered regions, which interfere with protein crystallization (Yang, 
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Thomson et al. 2005). After small-scale expression and solubility test, three proteins 
were selected for further structural study.  
 
FIGURE 1.12: RONN plot of probability of disorder against residue number. The threshold value 
(0.5) for disorder is indicated. Residues with a probability above 0.5 predicted to be disordered, 
while those below 0.5 are predicted to order.    
Name Predicted function Expression level description Strain 
TAG 3-methyladenine DNA glycosylase I 
Up-regulated in MSSA476, 
down-regulated in MRSA252 MSSA476 
PFK 1-Phosphofructokinase Up-regulated in MRSA252 down-regulated in MSSA476 MRSA252 
MK Mevalonate Kinase Up-regulated in MRSA252 down-regulated in MSSA476 MRSA252 
TABLE 1.2: List of the potential drug targets selected from MRSA252 and MSSA476 by 
differential expression level between the two disease-causing strains.    
1.4 Structural biology and Fragments-based drug 
discovery 
1.4.1 Structural biology  
Structural biology has been transformed biology over the last few decades, and more 
  30 
progress is coming. This will be driven by advances in automation of protein 
expression, characterization, purification, crystallization, crystal mounting, x-ray 
diffraction, model building and Nuclear magnetic resonance (NMR) spectra 
interpretation.  
 
X-ray crystallography is the most widely used method to investigate the 
three-dimensional (3D) structure of the protein. A protein that is essential for growth, 
survival or antibiotic resistance of a pathogen, is a potential drug target. The 
high-resolution crystal structure of such a protein can provide valuable information in 
drug discovery, especially if the structure of the protein contains potential lead 
inhibitor compounds bound at the active site. Protein complexes with drug can be 
obtained via either co-crystallization protein with compounds or the soaking method. 
Crystals can be soaked with individual hits separately or cocktails of up to 10 
fragments from a library. The structure of the target protein in complex with the 
substrates or other compounds can help to identify the key residues that are involved 
in ligands recognition and catalysis.  
 
The NMR method doesn’t require any crystalline materials and works in solution or 
solid-state. NMR in solution depends on obtaining a sharp spectrum which in turn, 
depends on the rate of protein tumbling (Amano 2004). Large molecules which 
tumble slowly give broad weak band spectra which are difficult to interpret (Olofsson, 
Ippel et al. 2004). 
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1.4.2 Fragment-based drug discovery 
Target proteins can be screened against compounds in high-throughput screening 
(HTS) (selection). The conceptual basis of fragment screening is that instead using 
large numbers of complex molecules, screening small amounts of less complex 
molecules increase the probability of potential drug hits. The term high-throughput 
screening (HTS) refers to that using modern techniques, such as automatic robotics, 
data processing and analysis, sensitive detectors and computer modeling. Fragments 
discovery is thought currently more likely to give better potential drug leads.  
 
 
FIGURE 1.13: Fragments screening and normal compounds screening. 
The thermal shift measures the change of the unfolding temperature of 
protein/fragments complex. Fragments that bind to the protein stabilize it. This 
technique is capable of high throughput selection (Nettleship, Brown et al. 2008).  
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The potential hits from the thermal shift assay can be further verified by either nuclear 
magnetic resonance (NMR) spectroscopy or isothermal titration calorimetry (ITC) or 
biochemical assay. Results of fragment identification provide a rational basis and 
starting point for further drug design and also contribute to the understanding the 
interaction between protein and ligands.      
 
FIGURE 1.14: Schematic view of fragments-based drug discovery approach. 
  33 
Chapter 2  
“Structural studies of 3-Methyladenine 
DNA Glycosylase I from 
Methicillin-susceptible Staphylococcus 
aureus (MSSA), a member of the HhH 
DNA glycosylases family”     
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2.1 Summary 
3-Methyladenine DNA glycosylase I (TAG) from S. aureus was successfully 
expressed in C43 (DE3) cells in Luria Broth (LB) culture medium and purified by a 
two-step purification approach using nickel-affinity column and size exclusion 
column. The identity and integrity of the protein was determined by mass 
spectrometry and SDS-PAGE. Native crystals of TAG were obtained from a Hampton 
Classics Screen [0.1M Tris-HCl pH 8.5, 2 M ammonium sulphate] using the sitting 
drop vapour diffusion method. The native structure was determined to 1.70 Å and 
solved using single-wavelength anomalous diffraction (SAD) method. The structure 
in complex with 3-methyladenine was obtained and solved using molecular 
replacement (MR) method. Fluorescence spectroscopy was used to determine the 
protein activity. A thermodynamic analysis using a fluorescence-based method 
(thermo-fluor) was carried out to investigate binding interactions of several ligands to 
TAG. The high resolution crystal structures of TAG and thermodynamic data 
contribute to the overall understanding of the interaction between TAG and its 
substrate. These findings show that TAG specificity binds 3-MeA rather than the 
normal base adenine. 
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2.2 Introduction 
2.2.1 DNA damage and repair 
The genetic information encoded within the DNA sequence and the structure of DNA 
is the basis of all life (except virus). However, the genetic information carrier, DNA, 
is constantly exposed to various kinds of challenge (Lindahl 1993). A variety of 
intracellular reactions and environmental compounds can induce unwanted chemical 
modification in the DNA bases.  
 
Chemical reactions such as alkylation, oxidation or radioactive processes are all 
known (Friedberg, Aguilera et al. 2006). Moreover, DNA damage also occurs by the 
inherent chemical instability of nucleic acids during the replication process. If such 
changes are left uncorrected, the resulting lesion can cause genetic mutations or 
stalling of DNA normal replication which leading to cell apoptosis (Memisoglu and 
Samson 2000; Fromme and Verdine 2004). To defend against DNA damage, all 
organisms possess a series of self-defense mechanisms to repair the chemical change 
in their DNA and maintain the completeness, viability and stability of the genomic. 
(FIGURE 2.1)  
  36 
 
FIGURE 2.1: Chemical structure of typic al damaged DNA bases. Chemical groups not found in 
the normal DNA bases are shown in red label. Picture modified from (Krokan, Standal et al. 
1997) 
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The organisms have evolved a variety of strategies for protecting their own genetic 
information since life began. The Nucleotide Excision Repair (NER) and Base 
Excision Repair (BER) are the two critical DNA repair pathways for recognizing and 
excising damaged DNA lesions (Fujii and Yamagata 2000; Krokan, Nilsen et al. 2000). 
The NER pathway is a complicated DNA repair system (Ackerman and Iakoucheva 
2000; Dianov, Souza-Pinto et al. 2001), coordinating at least 20 different proteins to 
remove DNA adducts (Wood 1997), and about 30 other genes (Krokan, Standal et al. 
1997) to complete repair. The NER pathway is an alternative DNA repair pathway for 
the excision of DNA damage induced by alkylation or oxidative as a backup system of 
the BER pathway (Samson, Thomale et al. 1988; Reardon, Bessho et al. 1997). 
(FIGURE 2.2) 
 
FIGURE 2.2:  Schematic representation of cellular mechanisms evolved in the maintenance of 
the genome. Picture modified from (Krokan, Standal et al. 1997) 
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2.2.2 DNA glycosylases in Base Excision Repair pathway  
The BER pathway is considered as the most significant self-defense mechanism and is 
triggered by the detection and then removal of damaged or abnormal bases such as 
radiated, alkylated, oxidized bases and even bases missing purine/pyrimidine (bases) 
(Meira, Burgis et al. 2005; Allen, Johnson et al. 2006). The initial step is carried out 
by different DNA glycosylases such as 3-MeA DNA glycosylase I or II (Bjelland and 
Seeberg 1996; O'Rourke, Chevalier et al. 2000). These DNA glycosylases remove 
different types of chemically modified or damaged bases by cleaving of the 
N-glycosidic bond between a base and the deoxyribose moieties of the nucleotide 
residue. 
 
Once the abnormal base such as 3-MeA is recognized and removed by DNA 
glycosylases, the left remaining apyrimidinic/apurinc (AP) -site is then removed by 
AP-lyase or AP-endonuclease, which cleaves the DNA strand 3’ or 5’ to the AP-site, 
respectively (Korolev 2005). Deoxyribose phosphate residue is cleaved by 3’- 
phosphodiesterase and 5’- phosphodiesterase (Zharkov 2008). The resulting gap is 
filled by DNA polymerases. The DNA strand break is then repaired by either DNA 
ligase (I or III) at last to restore a normal and undamaged DNA strands (Seeberg, Eide 
et al. 1995; Baute and Depicker 2008) (FIGURE 2.3).  
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FIGURE 2.3:  Diagram of the Base Excision Repair (BER) pathways. Shown above are the 
repairing steps and main components evolved in the BER pathway. Picture modified from 
(Memisoglu and Samson 2000) 
At least eight different DNA glycosylases have been identified in the first step of the 
BER pathway (Krokan, Nilsen et al. 2000; Korolev 2005). All the DNA glycosylases 
could cleave glycosidic bonds of the damaged base, however they have differences in 
their range of ligand specificity (Seeberg, Eide et al. 1995; Korolev 2005). Most DNA 
glycosylases remove several structurally different damaged bases while a few of them 
have very narrow ligand specificities (Bjelland and Seeberg 1996; Korolev 2005). For 
instance, 3-Methyladenine DNA glycosylase II (AlkA) has the widest ligand 
specificity of all known DNA glycosylases and it can remove both damaged purines 
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and pyrimidines (Seeberg, Eide et al. 1995; Bjelland and Seeberg 1996). AlkA can 
remove 3-Methyladenine (3-MeA), 3-Methylguanine (3-MeG), 7-Methylguanine 
(7-MeG), 7-Methyladenine (7-MeA), O2-alkylcytosine, and O2-alkylthymine 
(Seeberg, Eide et al. 1995; Bjelland and Seeberg 1996; Hollis, Ichikawa et al. 2000). 
In contrast to AlkA, 3-Methyladenine DNA glycosylase I (TAG) in E.Coli is highly 
specific for 3-MeA base, although it also removes 3-MeG but with a much lower 
efficiency (Bjelland, Bjoras et al. 1993). Historically, DNA glycosylases that remove 
alkylated bases from DNA were called 3-Methyladenine DNA glycosylases, since 
3-MeA was the first identified base (Lindahl 1976). Many of these DNA glycosylases 
have overlapping ligands specificities and they can serve back-up for each other for a 
more efficient purpose (Ikeda and Seki 2001; Korolev 2005).  
2.2.3 The HhH DNA glycosylases family  
The crystal structure of E. Coli thymine glycol DNA glycosylase (EndoIII) indicated a 
novel DNA binding motif, which is called the Helix-hairpin-Helix (HhH) motif 
(Thayer, Ahern et al. 1995). The HhH motif has a length of ~20 amino acids (Doherty, 
Serpell et al. 1996), consist two α-helices linked by a short hairpin loop which having 
the coincidental sequences (Phe/Leu)-Pro-Gly-(Ile/Val)-Gly. This motif presents in 
many DNA-binding proteins such as DNA polymerases and DNA glycosylases (Nash, 
Bruner et al. 1996). The motif binds DNA in a sequence independent manner (Doherty, 
Serpell et al. 1996) and it is considered as the key elements that involved in 
interactions with DNA (Sawaya, Prasad et al. 1997; Rafferty, Ingleston et al. 1998).  
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At least six different DNA glycosylases have been identified currently are the 
members of the HhH DNA glycosylase family, and each of them has multiple 
homologues (Doherty, Serpell et al. 1996; Dodson and Lloyd 2002; Dizdaroglu 2005). 
Although the sequence identity is low (~10 %) among the HhH DNA glycosylase 
family members (Drohat, Kwon et al. 2002), they all exhibit the signature HhH motif 
for DNA-binding. The hairpin loop of the HhH motif exhibits the signature sequence 
pattern (Phe/Leu)-Pro-Gly-(Ile/Val)-Gly, indicates that these DNA glycosylases may 
share a common mechanism for DNA-binding (FIGURE 2.4)   
 
FIGURE 2.4: Sequence alignments of HhH family members. Alignment using BioEdit (Hall 1999) 
and DALI (Holm and Sander 1993) server. Identical residues in the sequences aligned are 
highlight in black, residues shaded grey indicate regions of sequence homology. The red box 
shows the conserved residues from the proposed DNA binding motif (HhH motif). The TAG, 
hOGG, AlkA, EndoIII and MutY each corresponds to 3-MeA DNA glycosylase I, 3-MeA DNA 
glycosylase II, thymine glycol DNA glycosylase and adenine-specific mismatch-DNA glycosylases. 
Comparative studies on these HhH DNA glycosylases have provided valuable 
information about enzymatic mechanism and helped identify the critical amino acids 
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that are essential for DNA and ligand binding such as 3-MeA DNA glycosylase II 
(AlkA) (Labahn, Scharer et al. 1996; Hollis, Ichikawa et al. 2000). The crystal 
structure of E. coli AlkA in complex with DNA revealed that it used an activated 
water nucleophile to cleave to adenine mispaired with guanine (Guan, Manuel et al. 
1998; Hollis, Ichikawa et al. 2000). This proposed mechanism is similar to 
adenine-specific mismatch-DNA glycosylases (MutY) (Fromme, Banerjee et al. 2004). 
Crystal structure of the human 8-oxoguanine DNA glycosylase (Bruner, Norman et al. 
2000) also shows a similar DNA-binding mechanism to EndoIII, they both use a 
catalytic residues Lys for the nucleophile attack (Mol, Kuo et al. 1995; Thayer, Ahern 
et al. 1995).  
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FIGURE 2.5: The HhH motif of DNA glycosylases. Schematic representation of the HhH 
subfamily DNA glycosylases structures. Helices are shown as grey cylinders and the HhH 
structure motif are shown in blue.  
Enzyme Source/Gene References 
Alkylbase-DNA glycosylases E. Coli (TAG) 
E. Coli (AlkA) 
H. Pylori (MagIII) 
(Drohat, Kwon et al. 2002) 
(Labahn, Scharer et al. 1996) 
(Eichman, O'Rourke et al. 2003) 
Adenine-specific mismatch-DNA 
glycosylases 
E. Coli (MutY) (Guan, Manuel et al. 1998) 
DNA glycosylases removing 
oxidized pyrimidines 
E. Coli (EndoIII) (Kuo, McRee et al. 1992) 
DNA glycosylases removing 
oxidized pyrines 
S. Cerevisiae (OGG) (Bruner, Norman et al. 2000) 
TABLE 2.1: List of some crystal and NMR structures of HhH subfamily of DNA glycosylases. 
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2.2.4 3-Methyladenine DNA glycosylase I (TAG) from S. aureus 
Alkylated bases such as 3-MeA, 3-MeG and 7-MeG are cytoxic and mutagenic DNA 
lesions (Klungland, Fairbairn et al. 1992; Klungland, Bjoras et al. 1994), failure to 
repair leads to the stalling of regular duplication of DNA (Boiteux, Huisman et al. 
1984), leading to more serious problems. Lesion repair begins by enzymatic 
hydrolysis of the glycosidic bond in DNA (the critical initial step of the BER 
pathway). The glycosidic bond of alkylated purine bases is usually hydrolyzed by two 
alkyl purine specific DNA glycosylases, 3-Methyladenine DNA glycosylase I (TAG) 
(Lindahl 1993) and II (AlkA) (Wyatt, Allan et al. 1999) (FIGURE 2.6). 
 
 
FIGURE 2.6: Schematic representation of BER intermediates results DNA strand breaks.  
Picture modified from (Memisoglu and Samson 2000) 
3-methyladenine DNA glycosylase I (TAG) (E.C 3.2.2.20) is known as one of the 
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smallest member of the HhH family of DNA glycosylases (~186 residues, Mw: ~21 
kDa) and has been shown that have a fairly narrow ligand specificity for the alkylated 
base, 3-MeA (Drohat, Kwon et al. 2002; Cao, Kwon et al. 2003). TAG shows very 
low overall protein sequences similarity compared with other HhH family DNA 
glycosylases (~8%). In S. aureus TAG, the highly conserved Pro-Gly-(Val/Ile)-Gly 
sequence pattern is not observed, replaced by Lys/Val-Phe-Val/Ile-Gly. Despite the 
low identity of overall sequences, S. aureus TAG still shows the conserved sequence 
motif at the HhH domain (FIGURE 2.7). 
 
FIGURE 2.7: Sequence alignment of the the HhH motif in TAGs. The Highly conserved hairpin 
loop in HhH motif is highlighted by the red box.  
The crystal structure of S. aureus TAG in complex with its product would provide 
valuable information to understand the DNA binding and base excision mechanism. 
There was no crystal structure of TAG bound to its product when we carried out this 
study, only a solution structure (NMR) of the E. coli TAG and an apo-form of TAG 
from Salmonella typhi (Cao, Kwon et al. 2003) (FIGURE 2.8). Maintaining of DNA 
is essential for the survival and evolution of S. aureus, making TAG a possible drug 
target. The protein is up-regulated in MRSA476, but down-regulated in MSSA252. 
Such proteomic differences implying that this protein may be important for the 
pathogenic strain. Structural study on this protein binding to its product and DNA will 
help us better understand the catalytic mechanism, and also contribute to inhibitor 
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design. 
 
FIGURE 2.8: Cartoon representation of the NMR structure of [A] E. coli TAG (PDB: 1P7M) and 
crystal structure of [B] Salmonella. Typhi TAG (PDB: 2OFK). Zn2+ ion is shown in grey sphere. 
2.3 Materials & Methods 
2.3.1 Overexpression and purification of TAG 
Protein Expression 
The TAG plasmid DNA (pDEST14-TAG) was transformed into E. coli C43 (DE3) 
cells (Novagen) and plated onto Ampicillin agarose plates. Single colonies were 
picked up and grown in 10 ml Luria Broth (LB) medium supplemented with 100 
µg/ml ampicillin at 37 ℃ overnight. The overnight cultures were used to inoculate 
500 ml of LB medium in 2 L flasks and grown to an OD600 of 0.6–0.8 at 37 ℃. The 
temperature was then reduced to 30 ℃ and protein over-expression was achieved by 
induction with 1.0 mM isopropyl β-D-1-thiogalactopyranoside (IPTG) for 6 hours. 
Induced cells were harvested by centrifugation at 10500 X g for 15 minutes (Beckman 
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Avanti J20-XP, JL8.100 rotor). The cells were then re-suspended in PBS and stored at 
-80 ℃ until required. 
Protein Purification 
After harvest, the induced cells were re-suspended in lysis buffer (150 mM NaCl, 2 
mM DTT, 20 mM imidazole and 50 mM Tris-HCl, pH 7.75) at room temperature for 
30 minutes. The cells were disrupted by sonication for 8 cycles of 45 seconds, 
interrupted by 1 minute periods on ice after addition of 20µg/ml DNAse I, one tablet 
of protease inhibitor was added. To ensure that the DNA was digested by DNAse I, 
the mixture was kept at 4℃ for another 20 minutes. After addition of 2 mM EDTA, 
the mixture was centrifuged for 45 minutes at 20,000 rpm at 4 C. Then the 
supernatant fraction was passed through a 0.22 µm syringe filter (Millipore) and 
collected for further purification. 
The supernatant containing TAG protein was applied to a charged Histrap Nickel 
Sepharose, high performance column (Amersham Biosciences), which had been 
equilibrated already with the lysis buffer. The unbound and weakly bound protein 
were removed by extensive washing with the wash buffer (300 mM NaCl, 2 mM DTT, 
30 mM imidazole and 50mM Tris-HCl, pH 7.75). Essentially pure TAG protein was 
eluted with the elution buffer (500 mM NaCl, 2mM DTT, 500 mM imidazole and 50 
mM Tris-HCl, pH 7.75). The eluted protein was then incubated with 1 ml of 2 mg/ml 
His-tagged tobacco etch virus protease (TEV) (approximate ratio 20:1 protein: 
protease) to remove the N-terminal polyhistidine tag (his-tag) at room temperature, 
the TAG protein and TEV mixture was dialyzed against 500 mM NaCl, 2 mM DTT 
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and 50 mM Tris-HCl, pH7.75 for 4 hours to remove the high concentration imidazole. 
The progress of cleavage was checked by SDS-PAGE, on completion the product 
mixture was passed through a 0.22 μM syringe filter membrane (Millipore) and a 
second Ni-NTA column to remove any uncleaved protein. The flow through was then 
concentrated to approximately 5 ml for size exclusion chromatography/gel filtration. 
Any precipitant was removed by centrifugation at 15000 X g for 15 min (4℃, 
Beckman Avanti J20-XP JA25.50 rotor). Size exclusion/gel filtration was applied on a 
Superdex™ 200 size exclusion chromatography column (Amersham Biosciences). 
The buffer used for column equilibration and gel filtration was consisting of 150 mM 
NaCl, 20 mM Tris-HCl pH 7.75 and 2 mM DTT. After the gel-filtration step proteins 
were judged to be pure by Coomassie™ Blue-stained gels and their integrity was 
confirmed by mass spectrometry (University of St Andrews). In total it was estimated 
30 mg pure TAG native protein was obtained from 4 L of cell culture. According to 
the results of pre-crystallization Test (PCT), the protein was then concentrated to 20 
mg/ml and 10 mg/ml respectively and dialyzed into 150 mM NaCl, 50 mM Tris-HCl, 
pH 7.75 prior to crystallization. Some of protein was flash-frozen in liquid nitrogen 
for long term storage.  
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FIGURE 2.9: Coomassie Blue stained SDS-PAGE gels of TAG. [A]TAG purification and TEV 
cleavage. [B] TAG gel filtration fractions. The protein standards marker is labeled in [A] and 
pure cleaved protein is highlighted by a black square. 
Binding buffer 500 mM NaCl, 2 mM DTT, 50 mM phosphate buffer, pH 7.75 (11.25 
mM NaH2PO4, 38.75 mM Na2HPO4), 10 mM imidazole 
Wash buffer 500 mM NaCl, 2 mM DTT, 50 mM phosphate buffer, pH 7.75 (11.25 
mM NaH2PO4, 38.75 mM Na2HPO4), 35 mM imidazole 
Elution buffer 500 mM NaCl, 2 mM DTT, 50 mM phosphate buffer, pH 7.75 (11.25 
mM NaH2PO4, 38.75 mM Na2HPO4), 500 mM imidazole 
Dialysis buffer  500 mM NaCl, 2 mM DTT, 50 mM phosphate buffer, pH 7.75 (11.25 
mM NaH2PO4, 38.75 mM Na2HPO4), 10% glycerol, 1 mM EDTA 
Gel-filtration buffer 
(Crystallization buffer) 
150 mM NaCl, 50 mM Tris-HCl buffer, pH 7.75  
TABLE 2.2: Buffer used in each step of S. aureus TAG purification.  
2.3.2 Crystallization, optimization and diffraction test. 
Crystallization 
Attempts were made to crystallize both apo-form TAG and a complex crystal. 
Concentrated protein in gel filtration buffer was screened using sitting drop vapour 
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diffusion technique. Two protein concentrations of 20 and 10 mg/ml were screened at 
20 ℃ with a drop size of 0.2 µl (containing 0.1 μl of protein and 0.1 μl precipitant), 
set up against 100 μl reservoir solution. The protein mixture drops were prepared 
using a nano-drop crystallization robot (Cartesian Honeybee), which is a part of the 
Hamilton-Thermo Rhombix system. Crystal screens employed in the study include 
JMac, Nextal-The Classics, Nextal-pH Clear, KBS Wizard, Nextal-JCSG, Nextal-PE. 
All the sitting drop trials were kept in a quiet room to avoid any disturbance and held 
at 20 ℃. 
 
TAG crystals was obtained in 24 hours from several conditions. Optimization of the 
initial 3 - 4 most visually promising hits, including at least one at each concentration, 
were performed to confirm crystals were protein crystals rather than salt. Improved 
crystals could be obtained from a number of optimized screens around the original 
conditions. The crystals grew to typically 0.1 to 0.2 mm3. The best crystals, judged by 
size and regular shape, were obtained from variation of Hampton Classics Screen 82 
[0.1M Tris-HCl pH 8.5, 2 M ammonium sulphate].  
  51 
 
FIGURE 2.10 Native TAG crystals. [A] Native TAG crystal grown in nano drop. [B] Native TAG 
crystal after optimization at similar condition. 
TAG protein in complex with 3-methyladenine (3-MeA) 
3-MeA (Sigma-Aldrich) was dissolved in the gel filtration buffer as a stock solution to 
a concentration of 100 mM/mL. Two concentrations of 20 mg/ml and 10 mg/ml of 
native TAG protein were pre-incubated with 10 mM and 5 mM 3-MeA solution for at 
least 6 hours at 4 ℃. The mixture was centrifuged at 15000 X g for 2 minutes 
(Eppendorf Centrifuge 5415D) to remove any insoluble ligand and protein precipitant. 
Crystallization trials were set up using the same method and system as the native TAG 
but at 4 ℃. 3-MeA and TAG complex crystals were grown in cold room (temperature 
= 4 ℃). All the drops were imaged and checked periodically.   
 
Initial crystals (FIGURE 2.11A) were found from a Hampton screen after about 7 
days. An optimization attempt around this condition was made to produce better 
quality complex crystals that were suitable for synchrotron. However, we could only 
  52 
grow crystal clusters (FIGURE 2. 11B) from optimization trails, no single crystal 
observed in all optimized drops. In order to get a single piece of crystal, we had to 
break the crystal cluster by needle under microscope. The flash-freezing method was 
used to store the single piece crystals for further data collection. 
 
 
FIGURE 2.11: TAG/3-MeA complex crystal and clusters. [A] TAG/3-MeA complex crystals 
grown in nano drop. [B] Crystals cluster of TAG/3-MeA complex after optimization at similar 
condition. 
To test the crystals diffraction quality, the in house X-ray generator (Rigaku-MSC 
Micromax-007 HF) system was used to screen the potential candidate crystals, which 
produced Cu Kα radiation (λ=1.5418Å) with Osmic mirrors. The crystals were firstly 
cryo-protected with 20% – 25% glycerol added to mother liquid before X-ray 
exposure. For the quick screen test, we use 30 second exposure time and 0.5 
oscillations range. The crystal diffract to 2.1 Angstrom at the edge (image not shown) 
which indicated that the crystals we had were protein crystals, and crystals from same 
condition might diffract to an even higher resolution at European Synchrotron 
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Radiation Facility (ESRF). Larger crystals from same condition were flash-frozen in 
liquid nitrogen for synchrotron data collection. 
2.3.3 Data collection strategy and initial processing 
Native TAG data collection  
TAG crystals diffraction data were collected on BM14 beamline at ESRF. Crystals 
were cryo-protected by adding 2 µl of 25% glycerol or PEG 200 (20%) to the protein 
drop. It seems PEG 200 gave more reliable cryo-protection than glycerol. Once a 
single crystal had been selected and soaked in cryo-protectant it was mounted on a 
cryo-loop and flash cooled to -173 ℃ in liquid nitrogen (Garman 1999). A high 
resolution data set that diffracted to 1.7Å was collected, using an exposure time of 10 
second and 1° oscillations angle per frame, and the crystal to detector distance was 
114.2 mm. 230 images were collected in this step. All the images were firstly indexed 
and integrated in DENZO and SCALEPACK (Otwinowsky, 1997). The program 
suggested that, the native crystal lattice belonged to the C 2 Laue group with cell 
dimension of a= 107.4 Å, b= 63.1 Å, c=38.4 Å, α=90.00, β=109.24, γ=90.00. The 
program POINTLESS, implemented within CCP4 program suite (Collaborative 
Computational Projects, Number 4 (Thornsberry 1994)), was used to confirm the 
Laue group and to suggest a space group C21.  
 
The TAG/3-MeA complex crystal diffraction data was collected on a single fragment 
of a big crystal cluster. The crystal was cryo-protected by adding 25% glycerol to the 
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mother liquid and frozen at -173℃ in liquid nitrogen. A 1.8 Å data set was collected 
from this single piece of crystal on ESRF ID14-2. The incident X-ray beamline had a 
wavelength of 0.934 Å. Data were recorded on a MARCCD detector with a crystal to 
detector distance of 112.63 mm. Indexing with MOSFLM revealed that the crystal 
had a same space group as native TAG.  
An attempt to solve the structure by Molecular Replacement (MR) was made with 
AMoRe (Navaza 1994), MOLREP (Vagin and Teplyakov 2000) and PHASER of the 
CCP4 program suite, but ultimately proved unsuccessful. The available crystal MR 
structure model was of low sequence homology (<20%), they failed to provide any 
significant solution, and the NMR model also failed to solve the structure (Protein 
Data Bank, Code: 1NKU, sequence identity 43%). However, as indicated by previous 
studies from the other group (Cao, Kwon et al. 2003; Kwon, Cao et al. 2003), TAG 
binds tightly with Zn2+, and were able to use the anomalous signal from this bound 
metal to solve the structure by Single-wavelength Anomalous Dispersion (SAD) 
technique. In order to obtain the strongest Zn anomalous signal, the wavelength was 
changed to 1.282 Å (the Zn2+ edge), the data were collected. Diffraction image and 
data collection statistics are shown in FIGURE 2.13 and TABLE 2.3, respectively.  
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FIGURE 2.12: Plot of theoretical f’ and f’’ for Zn and Se under different X-ray wavelength. 
Image was made by a web-based X-ray Anomalous Scattering Coefficients check tool 
http://skuld.bmsc.washington.edu/scatter/ 
 
FIGURE 2.13: X-ray diffraction pattern of TAG and TAG/3-MeA complex crystals. [A] native 
TAG determined to 1.7 Å at the ESRF, The resolution at the edge of the detector is 1.5 Å. [B] 
X-ray diffraction pattern of TAG/3-MeA complex crystals to 1.8 Å at the ESRF beamline 
ID14-EH2. The resolution at the edge of the detector is 1.6 Å. 
Data collection apo TAG SAD TAG/3-MeA complex 
Wavelength (Å) 1.282 Å 0.933Å 
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Resolution (Highset Shell) (Å) 50 - 1.70 (1.76 – 1.70) 30 - 1.80 (1.83-1.80) 
Unit cell 
a=107.46, b=63.10, c=38.47 
α = γ =90.00, β = 109.24 
a=107.46, b=63.10, c=38.47 
α = γ =90.00, β = 109.24 
Space Group C21 C21 
Unique reflections 24735 (5369) 93166 (17865) 
Average redundancy 9.2 (7.8) 4.1 (1.5) 
Data Completeness (%) 98 (86) 100 (92) 
I/σ (I) 24.8 (4.3) 18.6 (3.9) 
Rmerge* 0.05(0.304) 0.09 (0.49) 
TABLE 2.3:  Summary of data collection statistics for Native TAG crystal and TAG/3-MeA 
complex crystals.  
2.3.4 Structure solution and model refinement  
Native TAG structure 
The program SHELXC/D/E in CCP4 suite (Collaborative Computational Projects, 
Number 4 (Thornsberry 1994)) was used to identify the location of Zn and calculate 
the phases. SHELX C was used to prepare and analyze the SAD data. SHELX D was 
used to find the anomalous scatters and SHELX E to carry out density medication and 
calculated the phases. The TAG protein contains 2 cysteines, 1 Zn2+ atom is expected 
in the structure. The estimated solvent content is 56% with one monomer in the 
asymmetric unit. The CC All/Weak value from SHELX D is 31.47/23.70 which means 
a meaningful solution for this dataset. The heavy atom positions were used to 
calculate the phases, with density modification being used to break the phase 
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ambiguity. The initial phases were then improved by SOLVE/RESOLVE (Terwilliger 
2003). The program ARP/wARP (Perrakis, Morris et al. 1999) was then used to 
auto-build the TAG model. At this stage, 7 chains of 159 residues in total were built in 
the new model after 50 building cycles with an Rfactor/Rfree of 0.29/0.35. The rest of 
model building was straightforward. Manually model building and refinement was 
applied using the WinCoot (Emsley and Cowtan 2004) and REFMAC5 (Murshudov, 
Vagin et al. 1997) 
 
 
FIGURE 2.14: SHELX D output of the TAG dataset. 
3-MeA and TAG complex structure  
The 1.8 Å data sets of TAG/3-MeA complex crystal were indexed and merged in the 
space group C121, same as native TAG structure. The TAG/3-MeA complex structure 
was solved using the native TAG structure as the search model (PDB ENTRY CODE: 
2JG6). Automated molecular replacement with the PHASER program (McCoy 2007) 
in CCP4 program suite produced one solution with high rotation function Z (18.9) and 
translation function Z (TF-Z) score of 30.2, which suggested that the molecular 
replacement phasing with search model was successful. In this step, all residues were 
already given in the solution with an initial R factor and Rfree of 0.31 and 0.37 
respectively. WinCoot (Emsley and Cowtan 2004) and REFMAC5 (Murshudov, Vagin 
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et al. 1997) were subsequently used to build and refine the final TAG complex model.  
Both the native and the complex TAG structure were refined using the REFMAC5 in 
CCP4 Suite with translation, libration and screw rotation parameters (TLS) (Potterton, 
Briggs et al. 2003; Winn, Murshudov et al. 2003). Water molecules were added to the 
model automatically using ARP/wARP (Perrakis, Morris et al. 1999) in CCP4 
program suite. Ligand libraries were prepared using PRODRG (Schuttelkopf and van 
Aalten 2004). The 3-MeA molecule was modeled into the unbiased Fo-Fc map when 
the electron density was unambiguous. The final model was validated by a web-based 
protein structure validation service (http://molprobity.biochem.duke.edu/). 
Crystallographic figures were made using PyMOL™ (Version 1.1r1 – Delano 
Scientific) unless otherwise stated. The protein surface electrostatic potential was 
calculated using APBS (Adaptive Poisson-Boltzmann Solver), a PyMol™ plugin tool 
(Baker, Sept et al. 2001). The native TAG and complex model refinement statistics are 
summarized in TABLE 2.4 
 
Refinement Native TAG TAG/3-MeA complex 
Clashscore 3.01 2.9 
Rotamer outliers (%) 0.00% 1.00% 
Cβ deviations >0.25 Å 0 0 
Residues with bad bonds/angles (%) 0.00% 0.00% 
MolProbity Score (percentage (%)) 1.13 (99) 1.08 (100) 
Ramachandran favoured/outliers (%) 97.83% 98.49% 
R work 0.163 0.169 
R free 0.193 0.201 
r.m.s.d bond lengths(Å)/angles 0.009/1.093 0.008/1.147 
TABLE 2.4: Model refinement and validation statistics of native TAG and TAG/3-MeA complex.  
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2.3.5 Fluorescence spectroscopy assay for TAG 
The assay for TAG used a previously reported fluorescence method (Drohat, Kwon et 
al. 2002), which is based on fluorescence quenching of a protein tryptophan by 
adenine. The decrease in tryptophan fluorescence intensity of TAG (2µM) is 
monitored during addition of increasing amounts of 3-MeA (10 – 500µM) at 20 ℃. 
Excitation wavelength was 280 nm and emission 335 nm with buffer of 50 mM 
Tris-HCl pH7.5 and 150 mM NaCl.  
We also investigated the binding of the normal base adenine under same condition as 
3-MeA as the control experiments. All the reagents and assays auxiliary enzymes 
were purchased from Sigma-Aldrich. Three repeat measurements were carried out to 
make sure the data are consistent. Data were re-plotted in Grafit graphic analysis 
program. No significant binding of the normal base adenine was detected even at a 
high concentration of 350 μM. S. aureus TAG has a highly degree of ligand 
specificity for 3-MeA over adenine.  
 
 
FIGURE 2.15: chemical structure of normal base adenine and the alkylated base adenine,  
3-methyladenine. 
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FIGURE 2.16: Fluorescence spectroscopy assay for TAG/3-MeA binding at 335 nm. 
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FIGURE 2.17: Fluorescence spectroscopy assay for TAG/adenine binding at 335 nm.  
2.3.6 Thermofluor study on S. aureus TAG 
The fluorescence-based thermal shift assay (Thermofluor) is applied for the fragments 
screening method for finding the potential hits for the target protein. The changes of 
protein thermodynamic stability upon fragments binding are evaluated by a thermal 
unfolding curve. The midpoint temperature (Tm) of the protein unfolding transition is 
considered as the key guideline for the fragments evaluation.  
The Thermofluor assay for TAG fragments screening was performed in a 
commercially available real-time PCR instrument (Lo, Aulabaugh et al. 2004), where 
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thermal melting curves of buffer/fragments condition can be screened rapidly in 
high-throughput mode (96 samples in 2 hours).  
 
Sample preparation  
The TAG protein used in this thermo shift assay was also expressed in E. coli C43 
(DE3). Purification of the protein was performed as same as described previously, the 
TAG Gel-filtration buffer was consisting of 150 mM NaCl, 20 mM Tris-HCl pH 7.75, 
10 mM b-mercaptoethanol and 2 mM ethylenediaminetetraacetic acid (EDTA). The 
protein was concentrated to 50 mM/ML and kept at -80℃ for further use. The original 
stock 5000X concentrate SYPRO Orange (molecular probe, Dye) (Invitrogen) in 
DMSO was firstly diluted to 25X by TAG gel-filtration buffer. All the compounds 
were dissolved in DMSO to a final concentration of 200 mM and kept at 4 ℃ for 
further use.  
 
Thermofluor assay 
To apply the Thermo shift assay, solutions of 5 µL SYPRO Orange, 5 µL TAG protein, 
4.5 µL compound solution, and 35 µL TAG gel-filtration buffer were added to the 
well of a 96-well iCycle iQ PCR plate (Bio-Rad, Hercules, CA). For the control 
samples, 5 µL DMSO and buffer was added instead of compounds solution. All the 
plates were sealed and heated in an iCycle iQ5 Real-Time PCR detection system 
(Bio-Rad) from 25 ℃ to 98 ℃ in increment of 0.5 ℃ per minute. The fluorescence 
intensity of each well of the plates was monitored and recorded automatically by a 
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charge-coupled device (CCD) camera. The wavelengths of excitation and emission 
were 490 and 530 nm. Measurements were repeated twice. The melting curves were 
generated by the program iCycler iQ Optical System. The data could be further 
processed using the same program and Origin. Those fragments that induced a shift of 
Tm over 2 ℃ were considered as positive hits.  
 
 
FIGURE 2.18: The fluorescence-based thermal shift assay.  
Results / Potential hits 
16 potential hits out of 476 fragments were obtained by thermal shift assay against 
TAG. 6 of them were considered as obvious improvement.  
 
Fragments Structure Formula ΔTm (℃) 
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1-methyl-5-(trifluoromethyl)-1H-pyrazol
-3-ol N
N
F
F
F
OH
CH3  
C5H5F3N2O 2 
3,5-dimethyl-4-isoxazolecarbonitrile 
N
O
N
CH3
CH3
 
 
C6H6N2O 3 
[2-(1H-pyrrol-1-yl)phenyl]methanol N
OH
 
C11H11NO 3 
[4-(2-furyl)phenyl]methanol O
OH
 
C11H10O2 4 
(4-methyl-4H-thieno[3,2-b]pyrrol-5-yl)m
ethanol N
S
CH3
OH
 
C8H9NOS 4 
4-methyl-2,1,3-benzoxadiazole 
 
N
O
N
CH3
 
C7 H6 N2 O 6 
TABLE 2.5: The positive hits of the thermal shift assay for TAG 
The top hits for TAG are quite similar to the real TAG product, 3-methyladenine 
(3-MeA). They all have a benzene ring group linked to a NH2 group. It seems that this 
part in protein – compound interactions is vital.  
However, there are so many other factors influencing the results of the thermal shift 
assay, the protein stability is highly susceptible to buffer condition such as 
temperature, salt type and concentration, pH and ionic strength of the buffer. The next 
step is producing some complex crystals with these potential fragments by either 
co-crystallization or cocktail soaking techniques.  
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2.4 Results & Discussion 
2.4.1 Overall structure of TAG and TAG/3-MeA complex  
TAG overall crystal structure 
The final refined native TAG structure model consists of 186 residues with an Rfactor 
and Rfree of 0.16/0.20. The monomer structure appears as an “ellipse shape” and 
contains 10 α-helices and 2 β-sheets. The final model of TAG/3-MeA complex 
monomer has 188 residues. The two additional residues (Gly-Ala) were attached to 
the N-terminus and result from the cleavage of His-tag. An examination of the Protein 
Data Bank (PDB) for similar structures using the web-based protein structure 
comparison service SSM at European Bioinformatics Institute (EBI) 
http://www.ebi.ac.uk/msd-srv/ssm/ (Krissinel and Henrick 2004) shows that the S. 
aureus TAG shared a common overall fold with other TAG. The r.m.s.d with these 
monomers is in the range 1.2 – 1.8 Å. (TABLE 2.6) 
 
Source Nalign r.m.s.d(Å) Seq identity Citation 
E. coli TAG (1P7M) 174 1.79 43% (Cao, Kwon et al. 2003) 
S. typhi TAG (2OFK) 177 1.26 40% (Metz, Hollis et al. 2007) 
TABLE 2.6: strucuture alignment of S. aureus TAG using SSM at European Bioinformatics 
Institude (EBI) http://www.ebi.ac.uk/msd-srv/ssm/ (Krissinel and Henrick 2004). Nalign indicates 
the residues aligned.  
The TAG structure consists of two main domains. Helices α1- α8 consist the bottom 
domain (large domain), this domain is highly conserved in HhH DNA glycosylase 
family (Mol, Kuo et al. 1995; Eichman, O'Rourke et al. 2003) and contains the HhH 
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DNA binding motif. The HhH motif in TAG is composed by helices α9, α10 and the 
loop between them (FIGURE 2.21). This signature HhH motif is mainly responsible 
for DNA binding (Fromme and Verdine 2002; Metz, Hollis et al. 2007). β-strands β1, 
β2 and the N-, C-terminal loop consist the upper domain (small domain). Structural 
comparison indicates the small domain is less conserved among the HhH DNA 
glycosylase members.  
 
 
FIGURE 2.19: Stereo view of overall structure of TAG in complex with 3-MeA monomer A. Zn2+ 
iron is showing as a green sphere, the product 3-MeA is showing as stick in green and blue color 
and sulfate is showing as stick in red and yellow. N-Terminal is shown in blue, C-Terminal starts 
from the orange loop. All the helices and sheets are labeled. 
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FIGURE 2.20: Structure-based sequence alignment of S. aureus, S.typhi, E.coli TAG. The 
secondary structural elements of TAG are shown. Sequence alignment using ClusterW (Larkin, 
Blackshields et al. 2007) and ESpript (Gouet, Robert et al. 2003). 
 
FIGURE 2.21: Stereo view of crystal structure of TAG/3-MeA complex. The HhH motif is labeled 
and highlighted in yellow. The remaining conserved helical domain of the HhH glycosylase 
subfamily is shown in orange. The structures elements are unique to TAG are colored in green. 
3-MeA is shown in green and blue sticks to indicate the binding pocket of TAG. Zn2+ ion is shown 
in grey sphere.  
  68 
A web-based “protein interfaces, surfaces and assemblies” (PISA) analysis software 
http://www.ebi.ac.uk/msd-srv/prot_int/pistart.html (Krissinel and Henrick 2005) 
indicates that both the apo-form S. aureus TAG and complex structure are monomers 
and this is consistent with gel filtration result. There is no major structural difference 
observed between the apo-form and complex TAG structure. Other members of HhH 
DNA glycosylases are also reported to be monomeric such as S. typhi TAG (Eichman, 
O'Rourke et al. 2003; Metz, Hollis et al. 2007) and MagIII (Eichman, O'Rourke et al. 
2003). A Zn2+ ion is bound at the same location as the apo-form TAG structure. A 
sulfate molecule is observed in TAG/3-MeA structure, presumably from the 
crystallization condition. A 3-MeA molecule is bound at the active site, and the 
surface electrostatic charge is strongly negative. The loop in the signature HhH motif 
has a positive electrostatic surface. 
 
The Zn binding site is located at the centre of N-terminal loop and C-terminal loop 
(FIGURE 2.22). This binding site has as might be expected, a strong negatively 
charged electrostatics surface. Four conserved residues (Cys4, His17, His175 and Cys 
179) ligate the Zn ion within the normal Zn atoms distance. The distance of each 
residue to the Zn is 2.3 Å, 2.1 Å, 2.1 Å and 2.3 Å, respectively. Cys4 and His17 both 
from N-terminal loop while His175 and Cys179 are from C-terminal loop. The Zn ion 
seems likely act as a pin that tethers the N-terminal and C-terminal loops, stabilizing 
these flexible structure elements and holding the active site, also increasing the 
overall stability of the whole structure (Drohat, Kwon et al. 2002; Kwon, Cao et al. 
2003).  
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FIGURE 2.22: Cartoon representation of the Zn2+ binding site of S. aureus TAG. The 
solvent-accessible surface of TAG colored based on the electrostatics potential from -7 to +7 kT/e, 
calculated using ABPS tools in PyMol™. Positive charge is shown in blue and negative charge is 
shown in red.  
 
FIGURE 2.23: Stereo view of the Zn2+ binding pocket. Zn2+ ion is shown in grey sphere. 
Hydrogen bonds are depicted as black dashed lines. Residues that might interact with the Zn2+ 
ion are labeled in black letters. 
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The same Zn binding motif is also found in other structures of the TAG family such as 
E.coli TAG (Kwon, Cao et al. 2003) and S. typhi TAG (Metz, Hollis et al. 2007). 
Sequence alignment of TAG family protein shows this “Cys-His-X-His-Cys” motif is 
highly conserved (FIGURE 2.24). This Zn binding structure motif is distinct from the 
other normal “Zn2+ finger motif” found in eukaryotes (Berg 1990; Berg 1990) and 
other DNA glycosylases like human OGG (Fromme and Verdine 2002) and MutM 
(Gilboa, Zharkov et al. 2002). The normal Zn2+ finger motif in these structures are 
similar, they usually consists of 2 – 4 cysteines, and the order of these residues is 
usually Cys-X-Cys-X-Cys-X-Cys (Berg 1990; Kwon and Smerdon 2003), X 
represents up to about 20 amino acids. The normal Zn2+ finger motif stabilizes the two 
adjacent β-sheets and α-helix, which cluster in the region of a turn (Jasanoff, 
Kochoyan et al. 1992; Kirthi and Savithri 2003). However the Zn binding motif in S. 
aureus TAG is composed of two Cys-X-His sub-motifs, separated by 158 amino acid 
residues. This arrangement in TAG is significantly different from other Zn2+ finger 
motifs (FIGURE 2.25).  
 
FIGURE 2.24: Sequence alignment of the conserved Cys-His-His-Cys structure motif of the TAG 
family. The sequences of the TAG family were obtained from BLAST search using S. aureus TAG 
sequence. The Zn2+-binding Cys-His-His-Cys cluster is highlighted in red box.  
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FIGURE 2.25: Cartoon representation of the Zn2+ snap motif in TAG and normal Zn2+ finger 
motif. [A] A stereo view of the Zn2+ binding site in TAG. [B] Cartoon representation of the normal 
Zn2+ finger motif. [C] Schematic view of the normal Zn2+ finger motif.  
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FIGURE 2.26: Solvent accessible surface of TAG colored according to electrostatics potential. 
[A.I].[A.II] Cartoon representation and surface electrostatics potential of TAG structure. 
[B].[C].[D] The solvent-accessible surface of TAG colored based on the electrostatics potential 
from -7 to +7 kT/e, calculated using ABPS tools in PyMol™. Positive charge is shown in blue and 
negative charge is shown in red. 3-MeA is shown as green and blue stick to indicate the ligand 
binding pocket of TAG. 
2.4.2 The recognition site of S. aureus TAG 
The helix α10 is close to the product 3-MeA (< 4.8 Å) and involved in active site, 
residues from this helix interact with 3-MeA directly. Although 3-MeA and adenine 
have similar structures, the electron density map shows clearly that the 3-MeA is 
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bound (FIGURE 2.27).  
 
FIGURE 2.27: Stereo view of unbiased Fo-Fc electron-density map (red mesh) contoured at 3 σ 
with the final refined 3-MeA superimposed. 
The 3-MeA binding pocket is constituted by the four helices α1, α2, α3, α10 and the 
loop between helices α2 and α3 (FIGURE 2.29). Helix α1 also involved in the Zn2+ 
binding motif, while α10 is a part of the HhH motif. The four helices are highly 
conserved in the HhH family of DNA glycosylases. The overlap between HhH motif 
and product recognition pocket is consistent with recognition of both DNA strand and 
an alkylated base. The recognition pocket shows a very strong negative electrostatic 
surface charge (FIGURE 2.28). The orientation of the ring is assigned by hydrogen 
bonds since the nitrogen and carbon atoms are indistinguishable at this resolution. 
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FIGURE 2.28: The electrostatics surface potential of the active site of TAG. The 
solvent-accessible surface of TAG colored based on the electrostatics potential from -7 to +7 kT/e, 
calculated using APBS tools in PyMol™. Positive charge is shown in blue and negative charge is 
shown in red. 3-MeA is shown in green and blue stick.   
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FIGURE 2.29: Stereo view of the active site of TAG. 3-MeA is shown in green and blue sticks. All 
the helices were labeled in black. 
A closer look of the product binding site of TAG revealed that in total 8 residues from 
helices α1, α2, α3 and α10 involved in 3-MeA binding. These residues form a deep 
hydrophilic cavity for the product and solvent to access. The 3-MeA is fixed by 
hydrogen binding and a series of interactions with residues in the active site. Tyr16 
from helix α1 and Glu38 from helix α2 hydrogen bond 3-MeA. Water molecules 
bridge from 3-MeA to the main and side chain of Trp46, Trp21, Phe6 and Ser164 
from helix α10. Trp46 stacks against the hydrophobic face of 3-MeA. Compared to 
the apo-form protein, the water molecules W1 and W2 remain unchanged after the 
3-MeA binding, however, three water molecules W3, W4 and W5 are replaced by 
3-MeA molecule. The 3-MeA molecule also recruits 3 water molecules, created a new 
water-mediated interaction network and may enhance the binding of 3-MeA (FIGURE 
2.30). 
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FIGURE 2.30: Stereo view of key interactions in the active site. [A]apo-form TAG protein. [B] 
TAG in complex with 3-MeA. Protein residues are shown in green, 3-MeA in green and blue, and 
water molecules as red sphere. Hydrogen bonds are depicted as black dashed lines. Residues that 
might interact with the ligand are labeled in black letters. 
Superposition of the 3-MeA binding site of apo-form TAG and TAG/3-MeA complex 
monomer A shows no major difference (FIGURE 2.31). Glu38 and Tyr16 directly 
interactions with the 3-MeA molecule and have moved towards to the ligand by 0.8Å. 
Trp46, Phe6 and Ser164 are slightly closer to the 3-MeA molecule (0.3 Å). The side 
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chain orientation change of His41 and Tyr13 reflects change in the water-mediated 
network upon 3-MeA binding (FIGURE 2.32).  
 
FIGURE 2.31:  Stereo view of superimposed structure of TAG/3-MeA and native TAG (stick 
view). The 3-MeA is superimposed to indicate TAG active site. Native TAG is shown in grey Cα 
trace. TAG/3-MeA complex is shown in green Cα trace. The Zn2+ ion is shown in blue sphere to 
indicate the Zn2+ binding site of TAG.  
 
FIGURE 2.32: Stereo view of superimposed binding site of TAG and TAG/3-MeA complex 
structures. The native TAG residues is shown in white, the TAG/3-MeA complex residues is 
shown in green, Native TAG and TAG/3-MeA complex share same black labels. 
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2.4.3 3-methyladenine recognition of TAG 
The results of fluorescence spectroscopy assay shows that S. aureus TAG has much 
stronger binding affinity for 3-MeA than adenine. This result matches that seen with 
the E. coli TAG (Bjelland, Bjoras et al. 1993; Drohat, Kwon et al. 2002). 
 
FIGURE 2.33: Tryptophan fluorescence studies of 3-MeA and noemal base adenine binding to 
TAG. TAG shows a 90% decreace in its Tryptophan fluorescence intensity upon binding 3-MeA 
(dark blue diamond) but not adenine (red dots). 
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FIGURE 2.34: Reploted data for TAG upon 3-MeA binding. The Kd for 3-MeA determined from 
these data is 59.7 μM. 95% confidence intervals, 50.72 – 68.75 (μM). 
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The main difference between 3-MeA and adenine on structure is that 3-MeA has a 
methyl group on the ring (FIGURE 2.35). This additional methyl group on 3-MeA 
create a rearrangement of electron, thus make the 3-MeA base positive charged in 
DNA context. Although residues Glu38 and Tyr16 in 3-MeA binding site should 
possess similar hydrogen bonds with adenine, the interaction with Glu38 is probably 
different. In neutral adenine the carboxylate which is electron rich that will clash with 
the electrons on adenosine. This clash will be significantly reduced by the presence of 
the positive charge on 3-MeA, which will tend to reduce electron density on the ring 
nitrogen atom. The electrostatics surface potential shows the recognition site is 
strongly negatively (FIGURE 2.36). The negatively charged cavity binds the 
positively charged 3-MeA is preference over the normal base adenine. TAG uses this 
“surface electrostatics selection” mechanism to ensure its specificity for ligand. Such 
“surface electrostatics selection” effect also observed in other members of HhH DNA 
glycosylases, such as H. pylori MagIII (Eichman, O'Rourke et al. 2003). MagIII can 
specific binding with the methylated adenine like 3-MeA, but binding affinity for the 
normal base adenine is low.   
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FIGURE 2.35: Chemical structure of the 3-methyladenine and normal base adenine. 
 
FIGURE 2.36: surface electrostatics potential of the active site of TAG [A] and MagIII [B]. The 
solvent-accessible surface of protein colored based on the electrostatics potential from -7 to +7 
kT/e, calculated using APBS tools in PyMol™. Positive charge is shown in blue and negative 
charge is shown in red. 
A feature of the TAG binding site is the “aromatic-rich” with stacking interactions 
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(Trp46). There are five aromatic residues surrounding the 3-MeA (FIGURE 2.37), Trp 
21, Trp46, Tyr13, Tyr16 and Phe6. This phenomenon, aromatic residues clustering 
around the electron-deficient purines, is a common feature and widely observed in the 
bacteria and animal 3-MeA DNA glycosylases (Hollis, Ichikawa et al. 2000; Lau, 
Wyatt et al. 2000) (Thayer, Ahern et al. 1995). These aromatic residues are rich in 
electrons, and such an electron-rich setting is well suited for positively charged 
alkylated purines. This aromatic effect has been demonstrated to be vital for the 
3-MeA recognition and binding (Hollis, Ichikawa et al. 2000; Eichman, O'Rourke et 
al. 2003) (Labahn, Scharer et al. 1996). Mutational studies on the aromatic residues in 
S. typhi TAG revealed that substitution of the active site aromatic residues such as 
Trp46Ala and Trp6Ala both resulted an approximately 10-fold drop of the base 
excision activity (Metz, Hollis et al. 2007). We predict that the distribution of active 
site surface electrostatic potential and the aromatic-rich effect are likely to enhance 
the 3-MeA recognition and binding for S. aureus TAG.    
 
FIGURE 2.37 Stereo view of the aromatic residues around 3-MeA at the active site of TAG. All 
the aromatic residues around 3-MeA are labeled.  
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2.4.4 3-MeA recognition of TAG 
3-MeA recognition in S. aureus TAG is mainly achieved by hydrogen bonds between 
the product and conserved active site residues Glu38 and Tyr16. A multiple sequence 
alignment shows that these two residues are highly conserved in TAG family 
(FIGURE 2.38). Mutational studies on these two residues of S. typhi TAG 
demonstrated the binding affinity of 3-MeA of the mutant Glu38Ala reduced affinity 
approximately 300-fold, whereas Tyr16Phe mutant reduced affinity only 12-fold 
(Metz, Hollis et al. 2007). These results are consistent with the mutational studies of E. 
coli TAG (Cao, Kwon et al. 2003) and indicate that these two residues are the key 
determinant for 3-MeA binding. The crystal structure of S. aureus TAG/3-MeA 
complex is consistent with the observation that Glu38 is the most important residue.  
 
FIGURE 2.38: Sequence alignments of TAG family members. Alignment using BioEdit (Hall 
1999) residues in the sequences aligned are highlight in black, residues shaded grey indicate 
regions of sequence homology. The red box shows the highly conserved residues Tyr16 and 
Glu38.   
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FIGURE 2.39: Interactions of 3-MeA and residues in TAG active site. R = Rest of potential 
interaction with DNA. This figure was generated by CHEMDRAW.  
The HhH structure motif is highly conserved in HhH DNA glycosylases and 
considered to be the key elements for DNA binding (Doherty, Serpell et al. 1996; 
Hollis, Ichikawa et al. 2000; Drohat, Kwon et al. 2002). Crystal structure of these 
DNA glycosylases in complex with DNA such as OGG (Bruner, Norman et al. 2000) 
and AlkA (Hollis, Ichikawa et al. 2000) show HhH motif is the main element binds 
with DNA. Based on the structures of AlkA/DNA complex, a model of S. aureus TAG 
in complex with DNA was constructed for structure comparison by superposition of 
the DNA from the S. typhi TAG/DNA complex model (PDB entry: 3D4V) onto the S. 
aureus TAG/3-MeA complex structure.  
The S. aureus TAG/3-MeA/DNA complex model shows that the modeled DNA is 
binds the HhH motif, and the electrostatic potential around the HhH motif is 
positively charged, consistent with recognition of negative charged phosphate. The 
electrostatics distribution is predicted to be essential for DNA binding (Eichman, 
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O'Rourke et al. 2003). The alkylated base binding site is close to the DNA (~ 6 Å). 
Such structural architecture should contribute to the binding of the 3-MeA. TAG uses 
the loop between α2 and α3 to insert the minor groove of the DNA strands for a closer 
binding purpose. The loop in the HhH motif is predicted to have significant 
interactions with the DNA strands. This model is also consistent with the S. typhi 
TAG/DNA model matches that determined by Eichman group (Metz, Hollis et al. 
2007) (PDB CODE: 2OFI). 
 
 
FIGURE 2.40: The structure of TAG-DNA complex model. The HhH structural motif is 
highlighted in blue. The remaining conserved helical domain of the HhH DNA glycosylase 
subfamily is shown in grey. The structures elements are unique to TAG are colored in green. DNA 
is shown in orange sticks. 3-MeA is shown in green and blue sticks to indicate the binding pocket 
of TAG. 
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Superimposition of the active site residues shows that the main residues that involved 
in ligand binding are highly conserved. His41 in S. aureus TAG corresponding to 
Gln41 in S. typhi TAG, while Phe6 in S. aureus TAG corresponding to Trp6 in S. typhi 
TAG, both are aromatic residues. This highly conserved active site setting indicates 
that they are using a common mechanism in 3-MeA recognition and binding. 
 
FIGURE 2.41: Stereo view of superimposed of the active site residues of S. aureus TAG and S. 
tphi TAG. The S. aureus TAG is shown in green, the S. typhi TAG is shown in grey. The key active 
site residues are labeled in green (S. aureus TAG) and black (S. typhi TAG), respectively. The 
3-MeA from S. aureus TAG are colored in green, the 3-MeA from S. typhi TAG are colored in 
grey. 
2.4.5 Future work  
This study has provided a general insight into the 3-MeA binding of TAG. However, 
questions were left for answers. We still need to further investigate the mechanism of 
TAG/DNA binding. Full DNA complex and further inhibition studies and genetic 
knockout studies are significant for inhibitor designing.                                            
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Chapter 3  
 
“Structural studies of Fructose 
1-phosphate kinase from 
Methicillin-resistant Staphylococcus 
aureus, a member of the 
ribokinase-pfkB family” 
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3.1 Summary 
Fructose 1-phosphate kinase (PFK) is a ribokinase-pfkB family enzyme that catalyzes 
the second step of the fructose metabolite pathway. The enzyme has been postulated 
to be active in S. aureus and related bacteria. In this chapter, the putative PFK 
over-expression, purification, crystallization and structure solution are described. The 
protein could not be expressed in soluble form using E. coli with IPTG induction. The 
soluble protein was however obtained using auto-induction at a lower temperature. 
Crystallization conditions for the native PFK were identified and the structure of PFK 
was obtained to 2.3 Å. The protein was characterized by a biochemical assay as a 
fructose 1-phosphate kinase. However all attempt to solve the structure of PFK in 
complex with fructose 1-phophate were unsuccessful due to low quality of complex 
crystals. A thermodynamic analysis using thermofluor method was also carried out to 
investigate binding interactions of different fragments to PFK.  
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3.2 Introduction 
3.2.1 Fructose, glucose and glycolysis  
Sugars are vital for cells because they are a source of energy and carbon. Sucrose, 
lactose, glucose, galactose and fructose are commonly used in the energy flux system 
(Balakrishnan and Van den Broeck 2005) Among these sugars, glucose is the most 
important one because it is the main energy source for most organisms (Fairclough 
and Houston 2004). Fructose is a structural isomer of glucose and is used in the 
metabolism. Ribulose, fucose and xylulose are relatively rare and are only processed 
by some specialized microorganisms (Staudacher, Altmann et al. 1999; 
Carretero-Paulet, Ahumada et al. 2002). In nature, fructose is commonly found at high 
levels in various varieties of fruit, in honey and in some root vegetable (e.g. yams or 
sweet potatoes) (Park and Yetley 1993). Fructose is the sweetest of all simple sugars 
(Binet, Rager et al. 1998; Ehringer, Chiang et al. 2001). Nowadays the overall 
consumption of fructose is increasing because of its used as high-fructose corn syrup 
(HFCS) in the food industry as a sweetener for candies, cakes and drinks (Luz, 
Rodrigues et al. 2008) 
 
After sugars are transported into the cell, they are phosphorylated by specific sugar 
kinases (Gschaedler, Thi Le et al. 1994). The addition of negatively charged 
phosphoryl groups prevents the leakage of neutral sugars through the cell membrane, 
  89 
trapping them inside the cell, in preparation for further digestion by catabolic or 
anabolic pathways (Crouzoulon 1973; Fujisawa, Riby et al. 1991). The main catabolic 
pathway is called glycolysis, with glucose as the key sugar source (Van Rooyen, 
McCarthy et al. 2002). In the glucose pathway, glucose 6-phosphate (G6P) is the 
product of the first phohsphorylation step by hexokinase (Bork, Sander et al. 1993). 
G6P is converted to fructose 1, 6-phosphate (F16P) via phosphoglucose isomerase 
and fructose 6-phosphate kinase (Selig, Xavier et al. 1997). This is the committed step 
in the glycolysis process, because the metabolite fructose 1, 6-phosphate is the key 
product for further glycolysis and fructose 6-phosphate kinase is the limiting enzyme 
(Draborg, Villadsen et al. 1999; Hansen, Arnfors et al. 2007). Following a series of 
chemical reactions, F16P is eventually converted to Acetyl-CoA by a series of 
enzymes and finally enters the tricarboxylic acid cycle (TCA-cycle). This process is 
shown in FIGURE 3.1 below. 
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FIGURE 3.1: Schematic view of the glucose glycolysis pathway. 
3.2.2 Fructolysis and fructose 1-phosphate pathway 
Some bacteria utilize fructose instead of glucose as their main sources of energy and 
carbon. In these cases, fructose is utilized by an alternative metabolic pathway that 
avoids the rate limiting enzyme (fructose 6-phosphate kinase) but still produces 
acetyl-CoA (Papadopoulos and Roe 1957) (FIGURE 3.1). The fructose metabolism 
usually occurs in the liver using a unique active enzyme system (Van Schaftingen, 
Detheux et al. 1994). In this fructose metabolic pathway, the first step is carried out by 
fructokinase (FK), which converts fructose into fructose 1-phosphate (F1P) (Gunther, 
Sillero et al. 1967). F1P is not only an intermediate in this pathway but also a 
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stimulator of glucokinase. F1P specifically binds to the regulatory protein of 
glucokinase, thus preventing it from inhibiting the enzyme, The activity  of 
glucokinase is affected by an inhibitory binding protein, the protein binding affinity 
for glucokinase is enhanced by binding F6P, and decreased by binding with F1P (Van 
Schaftingen, Detheux et al. 1994). The second enzyme in fructose metabolite pathway 
is fructose 1-phosphate aldolase, which break F1P down to D-glyceraldehyde and 
Dihydroxyacetone-phosphate for further chemical reaction (Hers and Kusaka 1953). 
In this case, fructose is catabolized directly through the fructose 1-phosphate pathway. 
This direct metabolic pathway has only been discovered in the liver and muscles 
(Hagopian, Ramsey et al. 2005).  
 
Fructose can also enter the glucose pathway (Niculescu, Veiga-da-Cunha et al. 1996). 
In this alternative route shown in FIGURE 3.2, the second step is replaced by an 
ATP-dependent phosphorylation reaction of fructose 1-phosphate by fructose 
1-phosphate kinase (1-PFK) that yields the critical metabolite in the glucose pathway, 
fructose 1, 6-bisphosphate (Davies, Detheux et al. 1990). In this process, fructose acts 
as a supplement for glucose to some extent because fructose can also be 
phosphorylated to F16P by the sugar kinases such as fructokinase and fructose 
1-phosphate kinase (Selig, Xavier et al. 1997). Both fructose metabolite pathways are 
essential for the survival of S. aureus (Kizaki and Sawada 1997).  
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FIGURE 3.2: Schematic views of the Fructose and the associated glucose pathway. The fructose 
metabolism pathway is highlighted in blue arrows. Key enzymes involved in fructose metabolism 
are indicated by blue box. Picture adopted from (Hagopian, Ramsey et al. 2005).  
3.2.3 Ribokinase-pfkB family 
Kinases that catalyze sugar phosphorylation are called sugar kinases. All of the sugar 
kinases can be classified into three major distinct nonhomologous superfamilies.  
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The hexokinase family contains many eukaryotic and prokaryotic sugar kinases with 
different specificities. The second is the galactokinase family (GHMP kinase family), 
which contains several bacterial and yeast galactokinases, mevalonate kinase, 
phosphomevalonate kinase and homoserine kinases. The third family, ribokinase 
family, comprises bacterium fructokinases, prokaryotic and eukaryotic ribokinases, 
the minor isoform fructose 6-phosphate kinase, fructose 1-phosphate kinase, tagatose 
6-phosphate kinase and a new member inosine-guanosine kinase (Bork, Sander et al. 
1993). Members from these three distinct families of sugar kinases appear to have a 
different 3D fold (FIGURE 3.3).  
 
 
FIGURE 3.3: Typical folds of three distinct kinase families. Including human glucokinase from 
hexokinase family, L. major mevalonate kinase from galactokinase family and S. aureus tagatose 
6-phosphate kinase from ribokinase family.    
The amino acid sequence search suggests that the putative fructose 1-phosphate 
kinase from S. aureus is a member of the ribokinase-pfkB family of carbohydrate 
kinase. The most closely related proteins suggested by a BLAST search are 
  94 
fructokinase, phosphotagatokinase, ketohexokinase, adenosinekinase and the minor 
fructose 6-phosphate kinase. Multiple sequence alignment shows that the putative S. 
aureus PFK has the conserved sequence motifs I and II (FIGURE 3.4) of the 
ribokinase family (Sigrell, Cameron et al. 1998; Li, Kwok et al. 2002; Zhang, 
Dougherty et al. 2004). The putative S. aureus PFK exhibits these characteristics to 
share a similar overall fold with the other members of the ribokinase-pfkB family.  
 
FIGURE 3.4: Multiple sequences alignment of 4 ribokinase family enzymes. Sequences are the 
putative S. aureus PFK (1PFK_STAAU), D-tagatose-6-phosphate kinase from S. aureus 
(LACC_STAAU), 6-phosphofructokinase from Escherichia coli (6-PFK_ECOLI) and human 
ribokinase (RBKS_HUMAN). Identical residues in the sequences aligned are highlighted in black, 
and residues shaded grey indicate regions of sequence homology. The two red boxes indicate the 
conserved motifs 1 and 2, which have been identified previously as the potential ATP/PPi binding 
motif for the ribokianse family. Sequence alignment was carried out using BioEdit (Hall 1999) 
and DALI (Holm and Sander 1993) server. 
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FIGURE 3.5: Localization of conserved structure motifs I and II in ribokinase family enzymes.    
3.2.4 Fructose 1-phosphate kinase (1-PFK) from S. aureus 
Fructose 1-phosphate kinase (systematic name ATP: D-fructose 1-phosphate 
6-phosphotransferase (E.C. 2.7.1.56)) is also referred to as 1-phosphofructokinase 
(1-PFK). This ATP-dependent enzyme is crucial for the alternative route of fructose 
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metabolites and for fructose entry into the glucose pathway. This enzyme was first 
identified in Bacteroides symbiosus (Reeves, Warren et al. 1966) and later in other 
organisms such as Pseudomonas putida and E. coli (Bang, Baumann et al. 1977; 
Orchard and Kornberg 1990). Substrates of 1-PFK and other members of 
ribokinase-pfkB family are quite similar (FIGURE 3.4), with only minor differences 
on the location of the hydroxyl group of the sugar moieties for enzymes such as 
tagatose 6-phoshate kinase (LacC) (E.C 2.7.1.144) and fructose 6-phosphate kinase 
(E.C 2.7.1.11). The reactions of these substrates are similar, the phosphate group is 
added to a primary hydroxyl group attached to a five membered ring, generating 
biphosphate products such as fructose 1, 6-bisphosphate.  
 
  
FIGURE 3.6: cartoon representation of the substrates for ribokinase family members.  
  97 
 
FIGURE 3.7: The reactions catalyzed by enzymes from ribokinase-pfkB family. fructose 
1-phosphate kinase (E. C 2.7.1.56), fructose 6-phosphate kinase (E.C 2.7.1.11) and tagatose -6 
phosphate kinase (LacC) (E.C 2.7.1.144).  
There was no structural information available on the structure of fructose 1-phosphate 
kinase when the project started. 2D gel electrophoresis in Peter Coote’s laboratory 
(University of St Andrews) revealed that the putative S. aureus PFK is up-regulated in 
MRSA252 and down-regulated in MSSA476. Structural studies on this enzyme will 
help us better understand the catalytic mechanism of this enzyme, and may contribute 
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to drug design.  
3.3 Materials & Methods 
3.3.1 Over-expression and purification of PFK 
IPTG induction and Auto-induction 
Attempts to express PFK using IPTG induction were unsuccessful since all the protein 
was recovered in the insoluble fraction, even when the expression was carried out at 
lower temperatures (16°C and 25°C). Next, protein over-expression was attempted 
using the auto-induction media as described by Studier. (Studier. 2005).The PFK 
plasmid was firstly transformed into Escherichia coli BL21 (DE3) cells (Novagen) 
and plated onto ampicillin agar plates. Single colonies were grown in 10 ml LB 
medium overnight, supplemented with 100 µg/ml ampicillin. Then 1ml of a 10 ml 
overnight culture was used to inoculate 50 ml of LB and cells were harvested, after 
overnight incubation at 37 ℃, at 2000 X g and re-suspended in 20 ml PBS. 500 ml of 
auto-induction growth medium in a 2L baffled flasks, supplemented with 100 µg/ml 
ampicillin, was inoculated with 5 ml re-suspended cells and grown at 37 ℃, with 
shaking at 300 r.p.m for 4 hours to start bacterial growth. The temperature was then 
lowered to 25 ℃ and left for 48 hours, allowing bacterial subsequent self-induction 
of protein expression and growth to reach saturation (OD600~5.0). Cells were then 
harvested at 10500 x g and then re-suspended in 50 mM Tris-HCl pH 7.75, 150 mM 
NaCl and 15 mM imidazole.  
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FIGURE 3.8: Comparison of IPTG-induced and auto-induced over-expression of PFK. 
Coomassie Blue stained SDS-PAGE gels of S. aureus PFK. [A.1] crudes flow through of TPTG 
induction [A.2] first elution of IPTG induction. [B.1]protein marker. [B.2] crudes flow through 
first part. [B.3] crudes flow through second part. [B.4]wash flow throgh. [B.5] first elution from 
nickel column. [B.6] second elution. 
Purification 
Soluble protein was firstly extracted by incubation with 100 µg/ml Lysozyme and 20 
µg/ml DNase I (Sigma) before lysis, followed by two passes through a Constant cell 
disruptor (Constant systems). The soluble and insoluble fractions were separated by 
centrifugation for 45 minutes at 75500 x g. The same purification procedure was used 
for PFK purification as described earlier for TAG (Section 2.3.1) except that sodium 
phosphate buffer (11.25 mM NaH2PO4, 38.75 mM Na2HPO4) was used in place of 
Tris-HCl. Eluted protein was incubated with 1 ml of 2 mg/ml tobacco etch virus 
protease (TEV) (approximate ratio 20:1 protein: protease) to remove the polyhistidine 
tag at room temperature in buffer containing 500 mM NaCl, 2 mM DTT and 50 mM 
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phosphate buffer, pH7.75 for 4 hours to remove the high concentration imidazole. The 
progress of cleavage was checked by sodium dodecyl sulphate polyacrylamide gel 
electrophoresis (SDS-PAGE). Although TEV protease was able to cleave the His-tag 
on PFK, it took much longer time than expected (typically <5 hrs). The protein had to 
be incubated at room temperature for over 5 days changing the TEV protease and 
dialysis buffer once a day. Although an optimization attempt on cleavage condition 
was performed by varying buffer, salt concentration, pH, temperature and glycerol, 
the best result was only 50 % cleavage after three days of incubation. (FIGURE 3.9) 
 
FIGURE 3.9: Coomasie Blue stained SDS-PAGE of PFK TEV protease cleavage in three days. [A] 
after 12 hours at 4 ℃; [B] after 36 hours at 4 ℃; [C] after 60 hours at 4 ℃ 
Although the His-tag was never fully cleaved, the second nickel column was able to 
separate the tagged and untagged protein. The protein-TEV mixture was passed 
through a 0.22 μM syringe filter membrane (Millipore) and a second Ni-NTA column 
to remove any non-cleaved protein, His-tag and TEV protease. Then the flow through 
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was concentrated to approximately 5 mL before further purification by size exclusion 
gel filtration. Any precipitant was removed by centrifugation at 35000 x g for 10 min 
(4℃, Beckman Avanti J20-XP JA25.50 rotor). Sample was applied on a Superdex™ 
200 size exclusion chromatography column (Amersham Biosciences). Each step of 
purification was monitored by SDS-PAGE. After the gel-filtration step, the protein 
was judged to be pure by Coomassie™ Blue-stained gels and their integrity was 
confirmed by mass spectrometry using University of St Andrews mass spectrometry 
service. In total it was estimated 16 mg pure PFK native protein was obtained from 4 
L of cell culture. According to the results of Pre-Crystallization Test (PCT), the 
protein was then concentrated to 12 mg/ml and 6 mg/ml and dialyzed into 150 mM 
NaCl, 20 mM Tris-HCl, pH 7.75 prior to crystallization. Some of protein was 
flash-frozen in liquid nitrogen for long term storage. Buffer used in each step were 
detailed in TABLE 3.1.  
 
FIGURE 3.10: gel-filtration elutions profiles and SDS-PAGE of the putative S. aureus PFK.  
  102 
 
Binding buffer 500 mM NaCl, 2 mM DTT, 50 mM phosphate buffer, pH 7.75 (11.25 mM NaH2PO4, 38.75 mM Na2HPO4), 10 mM imidazole 
Wash buffer 500 mM NaCl, 2 mM DTT, 50 mM phosphate buffer, pH 7.75 (11.25 mM NaH2PO4, 38.75 mM Na2HPO4), 35 mM imidazole 
Elution buffer 500 mM NaCl, 2 mM DTT, 50 mM phosphate buffer, pH 7.75 (11.25 mM NaH2PO4, 38.75 mM Na2HPO4), 500 mM imidazole 
Dialysis buffer  500 mM NaCl, 2 mM DTT, 50 mM phosphate buffer, pH 7.75 (11.25 mM NaH2PO4, 38.75 mM Na2HPO4), 10% glycerol, 1 mM EDTA 
Gel-filtration buffer 150 mM NaCl, 50 mM Tris-HCl buffer, pH 7.75  
TABLE 3.1: Buffers used in each step of S. aureus PFK purification.  
3.3.2 Crystallization and optimization of S. aureus PFK 
Purified PFK protein was concentrated to 12 mg/ml and 2mM DTT was added prior 
to screening for crystallization conditions. The sitting drop method was employed for 
crystal screening, using a drop size of 0.3 μl, containing 0.15 μl protein and 0.15 μl 
precipitant, against 80μl screen buffer. The nano-drop crystallization robot (Cartesian 
Honeybee) from Hamilton-Thermo Rhombix system was also used to perform this 
screening. The crystal screens employed for this initial crystal screening included 
JMac, Nextal-The Classics, Nextal-JCSG, Nextal-PEGs (Hampton Research). All the 
sitting drop trials were incubated at 20 ℃. Initial crystals were obtained from 
Hampton Classics screen condition 87 [0.2 M Ammonium acetate, 0.1M Sodium 
citrate tribasic dihydrate pH 5.6, 30% w/v PEG 400] and JMAC screen condition 74 
[0.1 M HEPES pH 7.5, 2.0M Ammonium Sulphate, 0.2M Lithium Sulphate] after 2 
days incubation. An optimization screen around these conditions was carried out to 
produce better quality crystals suitable for X-ray diffraction. Some large crystals were 
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observed in an optimized condition containing 0.2 M Ammonium acetate, 0.1M 
Sodium citrate tribasic dihydrate pH 5.6, 28% w/v PEG 400, using a drop with 3 µL 
protein and 3µL precipitant equilibrated against a reservoir of 100 µL buffer. The 
diffraction quality was tested in house using the Rigaku 007 rotating anode X-ray 
generator. Crystals were cryo-protected by adding 20% – 25% glycerol to the buffer 
above before being flash-frozen for synchrotron source data collection. The crystals 
are shown in FIGURE 3.11 
 
FIGURE 3.11: S. aureus PFK crystals. [A] Native PFK crystals grown in a nano drop from 
Hampton Classics Screen 87, 0.2 M Ammonium acetate, 0.1M Sodium citrate tribasic dihydrate 
pH 5.6, 30% w/v PEG 400. [B] PFK crystals after optimization at similar condition.  
In order to produce complex crystals of PFK with its substrate and co-factor, 
co-crystallization method was attempted using 5 mM substrate F1P and 5 mM 
AMP-PNP. AMP-PNP, an analogue of ATP, is resistant to hydrolysis because the O 
atom between γ- and β-phosphate is replaced by N atom. F1P and AMP-PNP were 
both dissolved in PFK gel-filtration buffer. The protein and ligands solution were 
mixed gently and pre-incubated for 6 hours at 4°. The protein and ligands mixture was 
then centrifuged at 35000 x g for 2 min (Eppendorf Centrifuge 5415D) to remove any 
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insoluble compounds and precipitated protein. Crystallization of PFK in complex with 
F1P and AMP-PNP was attempted using sitting drop method and screening buffers as 
described in Chapter 2. Crystals were appeared after approximately one week. The 
best crystals appeared in a Hampton PEGs Screen 27 [0.2M Sodium acetate 
trihydrate, 20 %w/v polyethylene glycol 3350]. These crystals were then optimized to 
produce larger crystals (FIGURE 3.12) 
 
FIGURE 3.12: S. aureus PFK complex crystals. [A] PFK complex crystals grown in a nano drop 
from Hampton PEGs Screen 27, 0.2M Sodium acetate trihydrate, 20 %w/v polyethylene glycol 
3350. [B] PFK complex crystals after optimization under identical conditions. 
3.3.3 Data collection and initial processing  
Native PFK  
Crystals were cryo-cooled in liquid nitrogen 25% PEG 400 as cryo-protectant. A 2.2 
Å dataset was collected on native PFK crystals at ESRF Beam-line BM14. 180 
images were collected using an exposure time of 10 seconds and a crystal to detector 
distance of 280 mM. The wavelength used for data collection was 0.976 Å. An 
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example of the diffraction pattern obtained is shown in FIGURE 3.13. The spots 
appeared to be split, but initial processing using MOSFLM seemed to work well, 
suggesting that the crystal lattice belonged to the P222 Laue group with cell 
dimensions of a=85.01 Å, b=160.26 Å, c=40.74 Å; α=β=γ=90.00°. Data were 
processed and integrated using these parameters and then merged in SCALA. 
Program POINTLESS suggested that the space group P212121. Data were indexed in 
this space group and merged using SCALA. X-ray data collection statistics are 
presented in FIGURE 3.13 and TABLE 3.2, respectively. 
 
 
FIGURE 3.13 X-ray diffraction pattern of S. aureus PFK crystals at the ESRF beamline BM14. 
The resolution at the edge of the detector is 2.26 Å. 
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Data collection Native PFK 
Wavelength  (Å) 0.976 
Resolution (Highset Shell) (Å) 19.7 - 2.30 (2.36-2.30) 
Unit cell a=85.01, b=160.26, c=40.74;  α=β=γ=90.00 
Space Group P212121 
Unique reflections 24100 
Average redundancy 4.8 (4.8) 
Completeness (%) 99.5(94.5) 
Rmerge 0.09(0.42) 
I/σ (I) 12.8(3.7) 
TABLE 3.2 Summary of data collection statistics for native PFK crystal collected at the ESRF 
PFK complex crystal data collection 
The in house X-ray generator (Rigaku-MSC Micromax-007 HF) system was used to 
screen the optimized PFK crystals in complex with F1P and AMP-PNP. The crystal 
was cryo-protected by adding 25% glycerol to the mother liquor before diffraction 
screening, 360 images were collected using 45 seconds exposure time with 0.5° 
oscillation angle. The wavelength and crystal to detector distance used in data 
collection were 1.5418Å and 70 mM, respectively. Unfortunately, as can be seen from 
the diffraction pattern, the spots are smeared in some area. As a result, the dataset 
could not be processed using either HKL2000 or MOSFLM. Despite several attempts, 
no higher or better diffraction could be obtained with PFK complex crystals.   
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FIGURE 3.14: X-ray diffraction pattern of S. aureus PFK crystals using an in-house X-ray 
generator system (Rigaku-MSC Micromax-007 HF). The resolution at the edge of the detector is 
3.2 Å. 
3.3.4 Data processing, structure solution and model refinement 
Native PFK data set 
The native PFK dataset was indexed and merged in space group P212121. The 
Mathews coefficient calculation suggested that each asymmetric unit contained two 
molecules, with a solvent content of 48%. Molecular replacement was attempted 
because a similar structure from another organism was found with 41% sequence 
identity in the PDB (fructose 1-phosphate kinase from Bacillus halodurans. PDB 
entry: 2ABQ). Using this structure as the search model, the program PHASER from 
CCP4 program suite was able to give a partial solution with rotation function Z of 
12.1 and translation function Z of 17.4 as the starting model.  
The initial solution from PHASER was improved using an in-house procedure 
developed by Dr Kenneth Johnson, which took the search models, and then generated 
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multiple new models. These models were subjected to the simulated annealing 
process in CNS, and the regions where the atomic coordinates of the models 
converged were used as a starting point for new model, the process was iterative. This 
method was used to build as much of the model as possible, resulting in 374 residues. 
Examination of the maps produced by this model in program Xfit showed a domain 
shift between the putative S. aureus PFK and 2ABQ structure. The domain was fitted 
using the real space rigid body refinement procedure in Xfit and SCRWL was used to 
correct the side chains of the model. Cycles of refinement in REFMAC5 and Xfit 
from CCP4 program suite were subsequently used to produce a starting model (Rfactor 
= 0.37). From this initial starting model, I refined the structure using WinCoot and 
REFMAC5 to refine and build the final model. Water molecules were added to the 
model automatically using ARP/wARPs. The final model was validated by a 
web-based protein structure validation service “MolProbity" (Lovell, Davis et al. 
2003) (http://molprobity.biochem.duke.edu/). The refinement and validation statistics 
of native PFK structure is summarized in TABLE 3.3 
 
Refinement Native PFK 
Clashscore 12.09 
Rotamer outliers (%) 2.19% 
Cβ deviations >0.25 Å 0 
Residues with bad bonds/angles (%) 0.00/0.00 
MolProbity Score (percentage) 1.98 (91%) 
Ramachandran favoured/outliers (%) 97.53/0 
R factor 0.215 
R free 0.276 
r.m.s.d bond lengths(Å)/angles 0.011/1.197 
TABLE 3.3: Model refinement and validation statistics of native PFK structure. 
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3.3.5 S. aureus PFK enzyme activity assay 
S. aureus PFK enzyme activity assays was carried out using Mass spectrometry 
(University of St Andrews), The experiment was carried out to differentiate the 
reaction product fructose 1,6-bisphosphate, which has a molecular weight of ~339 Da 
from the substrate fructose 1-phosphate (~259 Da). This difference can be 
distinguished by mass spectrometry analysis. The assay solution consisted of 100 mM 
ammonium pH 7.5, 3 mM F1P, 0.5 mM MgCl2 and 2.5 mM ATP. After pre-incubation 
at 25 ℃ the reaction was started by the addition of PFK at an appropriate dilution (2 
µg). All reagents were purchased from Sigma-Aldrich. Reactions in absence of ATP, 
F1P and S. aureus PFK under same condition were used for controls (data not shown). 
All the experiments were repeated twice to make sure the data was consistent. The 
mass spectrometry data are shown in FIGURE 3.16.  
 
 
FIGURE 3.15: Reaction of E.C 2.7.1.56, Phosphorylation of Fructose 1-phosphate by 1-PFK 
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FIGURE 3.16: Mass spectrometry analysis of the assay mixture before and after addition of PFK. 
[A] Mass spectrometry analysis of the assay mixture before PFK was injected. [B] Mass 
spectrometry analysis of the assay mixture after injection of PFK. The ion count is circled in red, 
indicating the very latge increace in the intensity of the peak at 399.05. 
The reaction product fructose 1, 6-bisphohsphate has a estimated mass of 339 m/z 
with hydrogen, 361 m/z with sodium ion. The count in red circle indicates the 
concentration of reaction product fructose 1,6-bisphosphate salt. Before the addition 
of putative S. aureus PFK, the 361.16 peak (possible Na adduct is very low. The small 
peak may be contaminating F16BP (although the peak at 399 is missing) (FIGURE 
3.16A). FIGURE 3.15B shows the mass spectrometry analysis of the assay mixture 
after injection of PFK with strong peaks at 399.05 (F16BP) and 361.05 (F16BP + Na). 
This result strongly suggested that the putative S. aureus PFK can catalyze the 
phosphorylation reaction of F1P to F16BP. 
The kinetics study on PFK was based on a coupled enzyme reaction (FIGURE 3.17) 
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using initial rates method. The PFK activity was measured by coupling the formation 
of F 1,6-BP to the oxidation of NADH via three enzymes, fructose 1,6-bisphosphate 
aldolase (F16P aldolase), triosephosphate isomerase (TIM) and glycerol 3-phosphate 
dehydrogenase (Davies, Detheux et al. 1990; Niculescu, Veiga-da-Cunha et al. 1996). 
The enzyme activity was determined by measuring the decrease of optical density at 
340 nm using a spectrometer at room temperature (25 ℃). The standard assay system 
was 1 mL solution mixture contained 100 mM Tris-HCl, pH 7.5, 0.2 mM NADH, 5 
mM MgCl2, 1 mM EDTA, 2 mM ATP and 5-8 units each of F16P aldolase, TIM and 
glycerol 3-phosphate dehydrogenase. The final volume of the reaction mixture was 1 
ml. The mixture was mixed gently and the back group rate for the oxidation of NADH 
was measured for 2 minutes before addition of PFK. The reaction was monitored for 
an additional 30 seconds. A unit enzyme activity is defined as the amount of enzyme 
producing 1 µmol fructose 1,6-bisphosphate per minute. The Km for F1P was 
determined using an enzymes assay mixture containing 2 mM ATP, 0.5 – 12 mM F1P, 
and 1µg of pure S. aureus PFK. All coupling enzymes and chemicals were tested in 
absence to make sure that the rate of the standard assay is not limited by them. All the 
reagents and assays auxiliary enzymes were purchased from Sigma-Aldrich. Three 
repeat measurements were carried out to make sure the data are consistent.  
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FIGURE 3.17: Chemical Diagram of the coupled reaction of formation of F 1,6-BP to the 
oxidation of NADH via three related enzymes, fructose 1,6-bisphosphate aldolase (F16P aldolase), 
triosephosphate isomerase (TIM) and glycerol 3-phosphate dehydrogenase. 
Data repotted in Grafit graphic analysis program. Km of S. aureus PFK for fructose 
1-phosphate obtained using the Michaelis – Menten equation. The apparent Km of S. 
aureus PFK for F1P was determined to approximately 410 µM when enzyme was 
measured in the presence of 1 mM ATP and 5 mM MgCl2. 
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FIGURE 3.18: Enzyme kinetics study on S. aureus PFK.The apparent Km of S. aureus PFK for 
F1P was approximately 410 µM when enzyme was measured in the presence of 1 mM ATP and 5 
mM MgCl2  
3.3.6 Thermofluor study on S. aureus PFK 
The Thermofluor assay is also applied for finding the potential hits for S. aureus PFK. 
The same sample preparation and assay protocol are employed as described before 
(Chapter 2.3.6). All the samples were repeated twice at the same condition. The 
melting curves were generated and analyzed by the program iCycler iQ Optical 
System. Positive hits are those fragments that induce a shift of Tm over 2℃.  
Results / Potential hits 
24 potential hits out of 476 fragments were obtained by thermal shift assay against 
TAG. 16 of them were considered as clearly shifting the thermal stability. 
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Fragments Structure Formula ΔTm (℃) 
5-amino-2-(1H-pyrrol-1-yl)benzonitrile 
 
 
  
C11 H9 N3 2 
3-methylbenzene-1,2-diamine 
 
 
  
C7 H10 N2 2 
pyridine-2,3-diamine 
 
C5 H7 N3 2 
isoquinolin-3-amine 
 
 
  
C9 H8 N2 2 
4-(trifluoromethyl)cyclohexan-1-one F
F
F
O
 
C7 H9 F3 O 2 
2-ethyl-6-methylpyridine 
NCH3
CH3
 
C8 H11 N 3 
4-hydroxy-1-methyl-1,2-dihydroquinolin
-2-one N O
OH
CH3  
C10 H9 N O2 2 
1-benzofuran-5-amine 
O
NH2
 
C8 H7 N O 2 
1-benzothiophen-2-ylmethanol 
S
OH
 
C9 H8 O S 3 
1-benzothiophene-3-carboxylic acid 
S
O
OH
 
C9 H6 O2 S 3 
4H-thieno[3,2-b]pyrrole-5-carboxylic 
acid N
S
O
OH
 
C7 H5 N O2 S 3 
4-methyl-4H-thieno[3,2-b]pyrrole-5-carb
oxylic acid 
N
NH2
 
C8 H7 N O2 S 3 
N
N
NH2
NH2
NH2
CH3
N NH2
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6,7,8,9-tetrahydrodibenzo[b,d]furan-2-a
mine 
O
NH2
 
C12 H13 N O 4 
1,3-benzodioxol-5-ol 
 
 
  
C7 H6 O3 3 
6-hydroxy-2,3-dihydrobenzo[b]furan-3-o
ne 
O
O
OH
 
C8 H6 O3 3 
3-chloro-4-fluorophenol 
Cl
F
OH  
C6 H4 Cl F O 4 
TABLE 3.4: The positive hits of the thermal shift assay for PFK 
3.4 Results & Discussion 
3.4.1 Overall structure of S. aureus PFK 
The final model of S. aureus PFK monomer consists of 306 amino acids residues with 
an Rfactor of 0.21 and Rfree of 0.26. The S. aureus PFK monomer appears as a 
“bowl-with- lid shape” with two distinct structural domains. There are 14 β-sheets and 
10 α-helices in a monomeric structure. An examination of the Protein Data Bank 
(PDB) for similar structures using the web-based protein structure comparison service 
SSM at European Bioinformatics Institute (EBI) http://www.ebi.ac.uk/msd-srv/ssm/ 
(Krissinel and Henrick 2004) shows that the S. aureus PFK shared a common overall 
fold with other members of ribokinase-pfkB family and the r. m. s. deviation of Cα 
atoms with these monomers is in the range 1.5 – 2.3 Å.  
 
O
O
OH
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Source Nalign r.m.s.d (Å) 
S. aureus tagatose 6-phosphate kinase (LacC) 296 1.86 
B. halodurans fructose 1-phosphate kinase 302 1.75 
E. faecalis tagatose 6-phosphate kinase 294 1.61 
E. coli fructose 6-phosphate kinase 289 1.86 
T. maritama fructose 1-phosphate kinase 282 2.28 
TABLE 3.5: Structure alignment of S. aureus fructose 1-phosphate kinase using SSM at 
European Bioinformatics Institude (EBI) http://www.ebi.ac.uk/msd-srv/ssm/ (Krissinel and 
Henrick 2004). Nalign indicates the residues aligned.  
The tertiary structure of a PFK monomer is composed of two domains (FIGURE 3.24). 
The large domain appears as 3 layers (α/β/α) like a sandwich, consists of 10 β-sheets 
and 10 α-helices and comprises the residues 1-5, 38-82, and 109-306. Residues 
109-217 present a typical Rossmann-fold (Sigrell, Cameron et al. 1998) in the centre 
of the large domain comprising of α3-α7 and β8-β10. β-strands β4, β5, β12-14 extend 
the entire length of these parallel β-strands. The central β-strands are surrounding by 5 
α-helices on each side. A smaller domain comprising of residues 9-36 and 88-102, 
forms 5 β-strands which attaches to the main domain like a lid. The four large strands 
β2, β3b, β6 and β7 of this domain form an anti-parallel sheet, the small strand sits 
apart β3b. The two domains are connected by four loops (residues 5-9, 36-38. 
82-88.102-109).  
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The structure of the monomer appears like an open clam shell with a large gap 
between both domains. These features suggest a potential flexibility at the connecting 
loops, which may result in conformational changes with the loops acting as hinges. 
The Rossmann fold structure architecture and the “4+1 β-sheets” lid domain are 
highly conserved among the pfkB family proteins (FIGURE 3.28). Structure 
comparison shows the predicted locations of active site for substrate and co-factor 
binding are likely to be similar to other members of ribokinase-pfkB family. These 
structures include Fructose-1-phosphate kinase from Bacillus halodurans (PDB code: 
2ABQ), D-tagatose-6-phosphate kinase from S. aureus (PDB code: 2JGV), fructose 
6-phosphate kinase from Escherichia coli (PDB code: 3CQD) and 
1-phosphofructokinase from Thermotoga. maritama (PDB code: 2AJR). All main 
structure elements are labeled in FIGURE 3.19 and FIGURE 3.20. 
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FIGURE 3.19: Schematic view of native PFK monomer A. N-Terminal is shown in blue, 
C-Terminal starts from the orange loop. Helices are shown in orange cylinder. β-sheets in large 
domain are colored in green arrows, β-sheets from the lid domain are colored in blue arrows. 
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FIGURE 3.20: Cartoon representation of the crystal structure of S .aureus PFK. Helices are 
shown in orange and labeled. β-sheets in large domain are colored in green. Β-sheets from the lid 
domain are colored in blue and numbered accordingly.  
 
FIGURE 3.21: Secondary structure alignment of S. aureus PFK monomer A. The secondary 
structure was assigned, using STRIDE (Frishman and Argos 1995) web-based software 
(http://webclu.bio.wzw.tum.de/cgi-bin/stride/stridecgi.py) and confirmed by visual inspection of 
the model. 
  120 
 
FIGURE 3.22: Cartoon representation and electrostatics surface potential of the active site of 
PFK. The solvent-accessible surface of PFK colored based on the electrostatics potential from -7 
to +7 kT/e, calculated using ABPS tools in PyMol™. Positive charge is shown in blue and 
negative charge is shown in red. F1P is superimposed to indicate the active site of PFK   
 
 
FIGURE 3.23: Ribbon representation of members of the pfkB family. Fructose-1-phosphate 
kinase from S. aureus (PDB code: 2JG5). Fructose-1-phosphate kinase from Bacillus halodurans 
(PDB code: 2ABQ), D-tagatose-6-phosphate kinase from S. aureus (PDB code: 2JG1) and 
fructose 1-phosphate kinase from Thermotoga maritima (PDB code: 2AJR)  
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A structure-based sequences alignment of the ribokinase family and ribokinase-pfkB 
subfamily enzymes indicates that there are several conserved structure motifs in these 
enzymes (FIGURE 3.29). Motifs I and II have been reported previously as the 
signature character for the ribokinase family members (Sigrell, Cameron et al. 1998; 
Cabrera, Caniuguir et al. 2006). Amino acid residues from these two motifs are 
considered to be vital for the phosphorylation process (Sigrell, Cameron et al. 1998; 
Li, Kwok et al. 2002; Zhang, Dougherty et al. 2004). Motif III has the sequence 
Val-Gly-Ala/Ser-Gly-Asp-Ser-X-Val and this conserved structure motif is located 
close to the γ-phosphate of AMP-PNP/ATP and the sugar binding site. Motif IV which 
has the sequence Ala/Ser-Gly-Ser-X-Pro, and is located around the phosphate groups 
of the co-factor, is believed to stabilize the transition state. Motif IV is involved in 
sugar base substrate binding and such architecture is believed to be critical for the 
phosphate transfer (Chapter 3.4.5). Motif III and IV are common to the 
ribokinase-pfkB subfamily members of carbohydrate kinase, but not to the ribokinase 
family members in general (Cabrera, Caniuguir et al. 2006; Miallau, Hunter et al. 
2007; Cabrera, Ambrosio et al. 2008). Motifs III and IV may be assigned as a 
signature structure motif of the ribokinase-pfkB family of carbohydrate kinases 
(Cabrera, Caniuguir et al. 2006; Miallau, Hunter et al. 2007). These features imply 
that with highly conserved active sites residues and locations (Chapter 3.4.3), the 
substrate and co-factor should occupy similar locations within the active sites in each 
structure.  
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FIGURE 3.24: Structural-based sequence alignment of ribokinase family members. A multiple 
structural-based sequence alignment of S. aureus PFK (PFK), Fructose-1-phosphate kinase from 
Bacillus halodurans (2ABQ), D-tagatose-6-phosphate kinase from S. aureus (2JG1), 
phosphofructokinase-2 from Escherichia coli (3CQD) and phosphofructokinase from Listeria 
innocua (3IE7). Identical residues in the sequences aligned are highlight in black, residues shaded 
grey indicate regions of sequence homology. The four red boxes indicate the conserved motifs in 
comparison. This alignment was generated with BioEdit program.  
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FIGURE 3.25: Cartoon representation of overall structure of PFK dimer [A] [B] [C] [D]The 
surface electrostatics potential of PFK. The solvent-accessible surface of PFK colored based on 
the electrostatics potential from -7 to +7 kT/e, calculated using ABPS tools in PyMol™. Positive 
charge is shown in blue and negative charge is shown in red.  
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3.4.2 Dimer interactions in S. aureus PFK 
S. aureus PFK appears as a dimer in crystal form and this is consistent with gel 
filtration results. These results reveal that S. aureus PFK forms a functional dimer in 
common with other members of ribokinase-pfkB-like family such as B. halodurans 
PFK and S. aureus LacC (Miallau, Hunter et al. 2007) in both solution form and 
crystal form. A web-based “protein interfaces, surfaces and assemblies” (PISA) 
analysis software http://www.ebi.ac.uk/msd-srv/prot_int/pistart.html (Krissinel and 
Henrick 2005) was used to investigate the interactions between two subunits. The two 
subunits in the dimer are related by crystallographic symmetry and associate with 
each other via the interactions between their small domains (lid domain) and some 
part of the four loops that linking the two domains. An interface area of 1297 Å2 is 
buried between the two monomers. β-sheets β3a, β3b and β7 from lid domain, along 
with the residues from the loop between β5 and β6 are the main elements that 
participated in monomer-monomer interactions. The β-sheets from the lid domain are 
placed face to face with the strand directions. In this 4+1 β-sheets domain, the 
smallest β-strand (β3a) between β2 and β3b interacts with the lid domain from the 
other monomer. This structure organization was initially identified and described as 
“β-clasp motif” in E.coli ribokinase (Sigrell, Cameron et al. 1998). The β-clasp motif 
is a main feature of the interface interactions between two subunits of the dimmer, the 
two lid domains come together to form a special “β-barrel” and rotate about 90 ° with 
respect to each other. The small β-strand (β3a) and the loop between β2 and β3b 
interact with β7 from the opposite monomer as a hook and an interaction parallel 
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ladder is formed by the residues from these structure elements. The interaction area of 
each monomer is extensive. This β-clasp motif is highly conserved and considered as 
a distinguishing feature of the ribokinase-pfkB family enzymes (Sigrell, Cameron et 
al. 1998; Sigrell, Cameron et al. 1999). Structure elements from the hinge segments 
are also involved in the interactions between two subunits. Residue Asp86 from the 
loop between β5 and β6 interacts with the residue Lys33 from the other subunit in the 
dimer also to contribute to the protein dimerization (FIGURE 3.26).  
 
FIGURE 3.26: Cartoon representations of the interactions of the β-clasp motif between two 
subunits. [A] Cartoon representation of the interaction interface of the interactions between two 
subunits. [B] 90 ° turn X-axis view. [C] A closer look at the interactions between the residues 
from β-clasp motif and β7 from the other subunit. N, O and H atoms are shown in blue, red and 
white, respectively. 
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3.4.3 The potential active site of S. aureus PFK 
The active site of S. aureus PFK can be predicted by superimposing with other similar 
structure. The proposed AMP-PNP/ATP binding site is located on the surface of the 
large domain, the cleft between helices α8-10 cluster and the four anti-parallel 
β-strands (β10-14). The proposed F1P binding site is located on the edge of the 
sandwich domain, close to the flexible hinge segments that link to the lid domain and 
the long loop between β9 and helix α4 (FIGURE 3.27). Modeling of ATP and F1P was 
tried with both superposition method and a visual docking program GOLD (Genetic 
Optimization for Ligand Docking) (Verdonk, Cole et al. 2003), respectively. Crystal 
structure of S. aureus LacC in complex with T6P and AMP-PNP (PDB entry: 2HFU) 
(Miallau, Hunter et al. 2007) was used as the model for superposition.  
 
The proposed AMP-PNP/ATP binding site is composed of helices α8, α9, β11, β12 
and the small turn between β11, β12. This pocket is perfectly shaped to accommodate 
the ribose group and the long chain of AMP-PNP/ATP. The surface electrostatics 
potential of the groove is strongly positively charged and quite close to the β- and 
γ-phosphate group of AMP-PNP/ATP. This setting can neutralize the negative charge 
of the transition state (FIGURE 3.27).  
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FIGURE 3.27: The proposed ATP binding site. [A] Stereo view of the proposed AMP-PNP/ATP 
binding site of PFK. [B] [C]. Electrostatics surface potential of the proposed AMP-PNP/ATP 
binding site of PFK. The solvent-accessible surface of PFK colored based on the electrostatics 
potential from -7 to +7 kT/e, calculated using ABPS tools in PyMol™. Positive charge is shown in 
blue and negative charge is shown in red. AMP-PNP is superimposed to indicate the potential 
ATP binding site of PFK.   
In the S. aureus PFK/AMP-PNP model, the ribose group of AMP-PNP/ATP is deeply 
buried in the binding pocket, between the loop that links the β-strands β11, β12 and 
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one side of the helix cluster α8-10. The tri-phosphate chain runs along the groove 
between α8 and the parallel strands β8, β9, sandwiched by motif II and motif III. The 
α-phosphate group is likely to accept the hydrogen bonds directly from Gly219 and 
Ser217. A water-mediated hydrogen bonds network is possibly involved with the 
α-phosphate group and Thr251. The β-phosphate group may accept some hydrogen 
bonds from Asn181 and Lys179. Residues Gly246, Gly248 and T251 from the 
conserved motif II were also predicted to interact with the β-phosphate group. Most of 
these active site residues are conserved except two residues Val273 and Thr277 
(equivalent to Asn278 and Gly282 in S. aureus LacC). The phosphate groups are the 
key elements in the reaction. Comparison of the active site residues related to 
AMP-PNP/ATP binding shows the residues that might have interactions with the 
phosphate groups are highly conserved in ribokinase-pfkB family. These are Gly246, 
Gly248 Asp249, Thr251from conserved motif II, Lys179 and Asn181 from motif III. 
The γ-phosphate may interact with the residues from conserved Gly-Ala/Ser-Gly-Asp 
motif II (246-249) (α8). Residues Gly246 and Asp249 would be able to form direct 
hydrogen bonds with the γ-phosphate group. In addition, the conserved residue 
Gly248 could provide extra hydrogen bond to this phosphate group (FIGURE 3.28) 
Such arrangement is believed to catalyze the transfer of phosphoryl group (Zhang, 
Dougherty et al. 2004). The active site would be large enough to bind with ATP and 
admit the magnesium ions and solvent around the phosphate groups of  ATP.   
  129 
 
 
FIGURE 3.28: Stereo view of the proposed ATP binding site of S .aureus PFK [A] and S. aureus 
LacC [B]. PFK atoms are colored in cyan. S. aureus LacC atoms are colored in white. AMP-PNP 
is shown in green to indicate the potential ATP binding site. N, O and P atoms are shown in blue, 
red and orange, respectively. All the potential residues that might interact with AMP-PNP are 
labeled in the order of S. aureus LacC/S. aureus PFK.  
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The predicted F1P binding site is located at the surface of the large domain, close to 
the four loops and helix α1. The potential flexible hinge segments may the binding 
site. The hydroxyl group on ring moiety of F1P is close to the γ-phosphate of 
AMP-PNP/ATP. The electrostatic potential around the phosphate group of the 
substrate is strongly positive charged, and it is likely that such a distribution stabilizes 
the negative charged transition state phosphate group. Analysis of docking results 
suggests that F1P binds to the residues from both two domains of PFK and residues 
from the “hinge” loops.  
 
 
FIGURE 3.29: The proposed F1P binding site in S. aureus PFK and S. aureus LacC. [A.I] 
Cartoon representation of the proposed F1P binding site of S. aureus PFK suggested by program 
GOLD. [A.II] Electrostatics surface potential of the proposed F1P binding site of S. aureus PFK. 
F1P is shown in cyan to indicate the potential binding site. Ligand libraries were prepared using 
PRODRG (Schuttelkopf and van Aalten 2004). The solvent-accessible surface of TAG colored 
based on the electrostatics potential from -7 to +7 kT/e, calculated using ABPS tools in PyMol™. 
Positive charge is shown in blue and negative charge is shown in red. 
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FIGURE 3.30: Stereo view of S. aureus PFK with modeled F1P superimposed with S. aureus 
LacC/T6P complex structure. S. aureus PFK is colored in blue, S. aureus LacC is shown in grey. 
Secondary structure elements from S. aureus PFK are labeled in black. C atoms of F1P are 
shown in cyan. C atoms of T6P are colored in white, O and P atoms are shown in red and orange, 
respectively. Ligand libraries were prepared using PRODRG (Schuttelkopf and van Aalten 2004).  
The C3 and C4 hydroxyl groups of F1P are likely to interact with residue Asp12 and 
Gly37 from motif I. These two residues may also help to fix the orientation of the C1 
hydroxyl group. Both Arg88 and Ser134 from the motif IV which are highly 
conserved in ribokinase-pfkB family are likely to have potential interactions with the 
C1 phosphate group of the substrate and such interactions are predicted to help 
stabilize the flexible phosphate group. Residues Asn90 from β6 and Asn102 from β7 
are predicted to recognize the C2 hydroxyl group (distance ~3.5 Å), respectively. 
Residues Lys38 from motif I and Asp249 from motif II locate around the C6 hydroxyl 
group of the docked F1P, these two conserved residues are also close to the 
γ-phosphate group of ATP and predicted to play important roles in the reaction. 
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FIGURE 3.31: Stereo view of the proposed F1P binding site. Protein C atoms are shown in 
marine blue, C atoms of F1P are shown in green. N, O and P atoms are shown in blue, red and 
orange, respectively. F1P is docked to indicate the proposed substrate binding site.  
Structure comparison between S. aureus PFK and S. aureus LacC indicates that these 
substrate-related residues are highly conserved. In LacC, residues Asp12 and Gly37 
(equivalent to Asp12 and Gly37 in S. aureus PFK) interact with the C3, C4 hydroxyl 
groups of T6P, while residues Ser136 and Arg88 (Ser134 and Arg88 in S. aureus PFK) 
form hydrogen bonds with the phosphate group of T6P. Asn41 interacts with the C5 
hydroxyl group of T6P. Only two active site residues, Cys90 and Leu103 (equivalent 
to Asn90 and Asn102 in S. aureus PFK) are not conserved. These two residues are 
conserved in other fructose 1-phosphate kinases, they are able to form much stronger 
interactions with the C2 hydroxyl group of F1P than residues Cys90 and Leu103 in 
LacC. Previous studies on fructose 1-phosphate kinase from other species such as E. 
coli indicated that the enzyme is specific for F1P over T6P, with no reaction observed 
in the assay when F1P was replaced by F6P or T6P (Davies, Detheux et al. 1990; 
Veiga-da-Cunha, Hoyoux et al. 2000). Our model predicts that N90 and N102 of S. 
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aureus PFK are positioned to recognize the C2 hydroxyl of F1P. In T6P, however the 
hydroxyl is on the opposite face of the sugar ring and thus presents a hydrophobic 
surface. This hydrophobic surface of T6P is matched by Leu103 (distance ~ 3.9 Å) in 
LacC. This mutual incompatibility of  
the C2 hydroxyl recognition site is the best candidate for the observed substrate 
discrimination.      
 
FIGURE 3.32: Stereo view of superimposed of the active site residues of S. aureus PFK and S. 
aureus LacC. [A] Stereo view of superimposed of all F1P binding site residues of S. aureus PFK 
and S. aureus LacC. [B] Stereo view of the two distinct residues that might interact with C2 
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hydroxyl group of F1P in S. aureus PFK and S. aureus LacC. [C] hydrophobic interactions in S. 
aureus LacC 
A model of F1P and ATP binding in S. aureus PFK is generated according to our 
prediction (FIGURE 3.33). Protein surface shows that both ATP and F1P can fit into 
the active pocket of S. aureus PFK. The surface electrostatics potential of ribose 
group of ATP and the ring moiety of the F1P are neutral, while the surface around 
phosphate groups of ATP and F1P are reasonable positively charged. We predict that 
such settings can significantly stabilize and neutralize the phosphate group during the 
phosphoryl transfer process.  
 
 
FIGURE 3.33: Stereo view of the proposed active site of S. aureus PFK. Protein C atoms are 
shown in marine blue, C atoms of the substrate are shown in green. N, O and P atoms are shown 
in blue, red and orange, respectively. Potential hydrogen bonds between protein and ligands are 
shown as black dashes. ATP, Mg ions and F1P are docked to indicate the proposed binding site, 
respectively. Main chains of the selected residues are hidden for clarity purpose.  
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FIGURE 3.34: Stereo view of electrostatics surface potential of the proposed ATP and F1P 
binding site of S. aureus PFK. The solvent-accessible surface of TAG colored based on the 
electrostatics potential from -7 to +7 kT/e, calculated using ABPS tools in PyMol™. Positive 
charge is shown in blue and negative charge is shown in red. AMP-PNP and F1P are 
superimposed to indicate the potential binding site of PFK.   
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Structure comparison between the apo-form of S. aureus PFK and complex structures 
of other ribokinase-pfkB family enzymes reveal a conformational change. When 
binding with the substrate, the region between lid domain and sandwich domain is 
closed down like a “clam shell”. The lid domain covers the groove between two 
domains, with the four flexible loops that linking the two domains act as the hinge 
joint. This closed conformation presumably holds the ligands more tightly and may 
create the catalytic environment for the reaction (FIGURE 3.35). 
 
FIGURE 3.35: The proposed conformational change in PFK upon substrate binding. The small 
domain (lid domain) is shown in marine blue. The β-strands in the large domain (sandwich 
domain) are shown in orange and the α-helices are shown in green. F1P and ATP are 
superimposed to indicate the proposed binding site of substrate and co-factor.  
The movements can be thought of as a small rotation of the large domain against the 
fixed small dimerization domain. Similar phenomenon (domain closure) of 
conformational change has been observed in some other members of the ribokinase 
family like 6-phosphofructokinase from Pyrococcus horikoshii OT3 (Currie, Merino 
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et al. 2009) and many other multi-domain proteins (Ito, Fushinobu et al. 2001; Cheng, 
Bennett et al. 2002). This domain movement is essential for the phosphoryl group 
transfer in its reaction (Sigrell, Cameron et al. 1998) and this strategy is well known 
and widely applied in nucleotide-dependent transferases . The catalytic amino acids 
are positioned at their proper location by such conformational change (Matte, Tari et 
al. 1998). As the domains close, the active site is set for catalysis bringing the 
hydroxyl and phosphate close together. 
  
 
FIGURE 3.36: Stereo view of the conformation change of open-form and closed-form structure. 
The open-form (apo-form) structure is shown in marine blue. The closed-form structure is shown 
in grey. 
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3.4.4 The proposed catalytic mechanism of S. aureus PFK 
The mass spectra results and activity assay have been used to confirm the putative S. 
aureus PFK. The apparent Km of S. aureus PFK for F1P was approximately 490 µM 
when enzyme was measured in the presence of 2 mM ATP and 5 mM MgCl2. This 
value is comparable to other PFKs. The S. aureus PFK is also capable of binding to 
the substrate F1P and co-factor ATP as reported for similar enzymes.  
 
 
Source Km for S. aureus PFK (mM) citations 
E. coli 0.36 (Veiga-da-Cunha, Hoyoux et al. 2000) 
A. aerogenes 0.75 (Sapico and Anderson 1969) 
C. difficile 0.16 (Davies, Detheux et al. 1990) 
S. aureus 0.49 This work 
TABLE 3.6: Km for S. aureus PFK and other PFKs. 
Structure-based and sequence comparison between S. aureus PFK and other 
ribokinase-pfkB family enzymes provide a general idea of the location of the substrate 
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and how the reaction proceeds. The predicted catalytic centre is located at the cleft 
between lid domain and sandwich domain, the interface between the substrate (F1P) 
and co-factor (ATP). The Lys38 from conserved motif I and Asp249 from conserved 
motif II are close to γ-phosphate group of AMP-PNP/ATP and C1 hydroxyl group of 
F1P. The side chain of Asp249 is likely to function as a base that attracts the proton 
from the C1 hydroxyl group of F1P, then a nucleophile is generated to attack the 
γ-phosphate group of ATP, leading to phosphorylation and eventually producing 
fructose 1,6-bisphosphate. Lys38 would serve to stabilize and neutralize the negative 
charge during the transition of phosphoryl group. This proposed catalytic mechanism 
of S. aureus PFK is similar to other ATP-independent phosphoryl transferases/kinase 
and consistent to the catalytic mechanism proposed by Sigrell (Sigrell, Cameron et al. 
1999).  
 
 
FIGURE 3.37: Selected sequences are strictly conserved in ribokinase-pfkB family enzymes. 
Identical residues in the sequences aligned are highlight in black, residues shaded grey indicate 
regions of sequence homology. The three highly conserved motifs are shown The two predicted 
key catalytic residues Lys38 and Asp249 are indicated by red arrows and labeled. This alignment 
was generated with the BioEdit program 
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FIGURE 3.38: Cartoon representation of the catalytic centre for S. aureus PFK. Protein C atoms 
are shown in marine blue, C atoms of F1P are shown in green. N atoms, O and P atoms are shown 
in blue, red and orange, respectively. F1P, AMP-PNP and the two key residues Asp249 and Lys38 
are shown to indicate the interactions with the hydroxyl and phosphate group. The potential 
interactions are shown as black dashes. 
The metal ion is a critical element for the reactions (Mathews, Erion et al. 1998; 
Arnfors, Hansen et al. 2006). Mg2+ ions are found within the active sites of related 
structures e.g. human adenosine kinase, and are proposed to establish the cation 
bridges between the γ- and β-phosphates of the ATP, or the β- and α-phosphate of ADP. 
Furthermore, Mg2+ ion and the side chains are involved in the creation of a 
water-mediated interaction network with other amino acids in active site. These 
interactions are critical for transition state stabilization (Abele and Schulz 1995; 
Sabini, Ort et al. 2003; Liu, Timm et al. 2006). This architecture is also predicted to 
help orient the side chain that involved in transition, stabilize any negative charge 
during the reaction. The Mg2+ ion may also be essential for making the P-O bond 
between the γ- and β-phosphate more sensitive to nucleophilic attack by polarizing the 
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P-O bond (Pappu, Gregory et al. 1994) (Schumacher, Scott et al. 2000). This 
Mg-nucleotide complex setting can facilitate the effective attack by the activated 
hydroxyl group of F1P.  
 
FIGURE 3.39: The proposed mechanism for the γ-phosphate of the ATP transfer to fructose 
1-phosphate by 1-phosphofructokinase.  
3.4.5 Future work  
Although we have solved the PFK native structure, the proposed mechanism of 
enzyme needs further experimental work, namely site directed mutagenesis. In order 
to understand the interactions between protein and ligand, better quality crystals of 
PFK in complex with its substrate F1P and AMP-PNP are needed. To further validate 
the thermofluor data, an NMR assay or co-crystallization is necessary. The 
compounds can now be tested for inhibition using the assay described here. 
Mutational analysis would also provide valuable information on enzyme activities and 
provide useful information for inhibitor design.  
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Chapter 4  
 
Structural studies of the mevalonate 
kinase from Methicillin-resistant 
Staphylococcus aureus, a member of 
the GHMP kinase family. 
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4.1 Summary 
Mevalonate Kinase (MK) is an important enzyme that catalyzes the first step in the 
Mevalonate pathway. The 32.4 kDa protein from S. aureus, has been over-expressed, 
purified and crystallized. The enzyme crystallizes in the space group P6222 with a 
cell dimension of a=b= 94.6, c=169.0; α=β= 90°. γ=120°. A data set diffracting to 2.2 
Å has been collected at ESRF, however molecular replacement attempts were 
unsuccessful. Heavy atom soaks were attempted by soaking various solutions into the 
native crystals. The structure was solved using multiple isomorphorus replacement 
(MIR). Citrate was bound at the active site and it was not possible to obtain a 
co-complex structure with mevalonate or  ATP analogue. A Thermofluor assay was 
also applied to investigate the interactions between the enzyme and some potential 
fragments. The enzyme was assayed for activity and kinetic constants determined. 
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4.2 Introduction 
4.2.1 Isoprenoids and the mevalonate pathway  
Isoprenoids are a class of organic compounds comprising a huge family of more than 
30,000 different natural products (Lange, Rujan et al. 2000; Wilding, Brown et al. 
2000). Isoprenoids are essential for cell membranes and cell wall biosynthesis 
(Reusch 1984), and are also involved in electron transport (Reusch 1984; Kwon, 
Bhattacharyya et al. 1996). Isoprenoids are normally synthesized from the five-carbon 
starter unit, isopentenyl diphosphate (IPP) (Reusch 1984). IPP is synthesized by two 
different pathways, the mevalonate pathway (Goldstein and Brown 1990) and a 
non-mevalonate pathway, the glyceraldehydes-3-phosphate pyruvate (GAP-pyruvate) 
pathway (Rohmer, Knani et al. 1993; Rohmer 1999) (Lange, Rujan et al. 2000). The 
mevalonate pathway (mevalonate-dependent pathway) is widely used by many 
organisms such as mammals, yeast and archaea (Barnes and Goodfellow 1971; Porter 
1985; Goldstein and Brown 1990). While the GAP-pyruvate pathway was discovered 
recently in some microorganisms and plants (Rohmer 1999; Kim, Stauffacher et al. 
2000; Wilding, Brown et al. 2000).  
 
The mevalonate-dependent biosynthetic route was first proposed in eukaryotes in the 
1960s reviewed in (Kuzuyama 2002). In this pathway, two molecules of acetyl 
coenzyme A (Acetyl-CoA) are first polymerized into acetoacetyl coenzyme A 
(Acetoacetyl-CoA), and then this intermediate combines with another molecule of 
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acetyl-CoA to give 3-hydroxy-3-methylglutaryl-CoA (HMG-CoA), which is reduced 
by HMG-CoA reductase (Wang and Tong 1999). Mevalonate is then double 
phosphorylated to mevalonate 5-pyrophosphate by mevalonate kinase and 
phosphomevalonate kinase, then decarboxylated by diphosphomevalonate 
decarboxylase and finally dehydrated to form the IPP for further biosynthesis 
(Goldstein and Brown 1990; Wilding, Brown et al. 2000; Wilding, Kim et al. 2000; 
Dewick 2002). (FIGURE 4.1) 
 
Some bacteria such as E. coli (Lange, Rujan et al. 2000; Kuzuyama and Seto 2003) 
can use the distinct GAP-pyruvate pathway to generate IPP. However, some 
Gram-positive bacteria such as Streptococcus pneumonia, Enterococcus faecalis and S. 
aureus (Wilding, Kim et al. 2000) can use the mevalonate-dependent pathway to form 
the IPP. Given its importance for membrane and cell wall biosynthesis, if any stage of 
this pathway is blocked, the growth of bacteria will be inhibited.   
 
  146 
 
FIGURE 4.1: Mevalonate pathway. The acronyms: MK, mevalonate kinase (ATP:(R)-mevalonate 
phosphotransferase, E.C 2.7.1.36); PMK, phosphomevalonate kinase (ATP: (R)- 
phosphomevalonate kinase, (E.C 2.7.4.2); and DPM-DC, diphosphomevalonate decarboxylase 
(ATP: (R)-5-diphosphomevalonate carboxy-lyase, E.C 4.1.1.33). 
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4.2.2 The GHMP Kinase family 
Kinase can be classified into three major distinct super-families according to their 
basic structure overall fold and sequence similarities (Azzi, Boscoboinik et al. 1992; 
Zhou, Daugherty et al. 2000; Andreassi and Leyh 2004) The first group is composed 
primarily of protein kinase, which usually use a conserved loop connecting two 
anti-parallel β-sheet for the binding of phosphate (Bossemeyer 1994; Zhou, 
Daugherty et al. 2000). The second group is called the classical 
phosphate-binding-loop-containing kinases, they share a common motif consisting of 
a helix-loop-strand, and use this loop for phosphate binding (Matte, Tari et al. 1998), 
for instance the homoserine kinases (Zhou, Daugherty et al. 2000). The third group 
include sugar kinases and actin, which use two β-hairpins to bind the phosphate group 
(Bork, Sander et al. 1993).  
Crystal structures of eukaryotic MK and bacteria MK show that this enzyme is a 
typical member of the GHMP kinase family, this family belongs to the second kinase 
group (Bork, Sander et al. 1993; Fu, Wang et al. 2002; Yang, Shipman et al. 2002) 
GHMP derive from its members Galactokinase (G), Homoserine kinase (H), 
mevalonate kinase (M) and phosphomevalonate kinase (P) originally (Tsay and 
Robinson 1991; Bork, Sander et al. 1993). These proteins share a common overall 
fold and a highly conserved motif with an invariant arrangement of 
Gly-X-Gly-Ser-Ser-Ala-Ala. (FIGURE 4.2). This motif was first identified in 1991 
(Tsay and Robinson 1991) and considered as the signature structure motif for GHMP 
kinase family. This motif is found as a loop between α-helix and a β-strand and is 
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believed to be involved in the phosphate group binding of ATP. (FIGURE 4.3) 
In the past 10 years, new members of GHMP kinase family have been identified, such 
as mevalonate 5-diphosphate decarboxylase (MDD) (Cordier, Lacombe et al. 1999),    
4-diphosphocytidyl-2C-methylerythritol kinase (CDPME) (Luttgen, Rohdich et al. 
2000) and isopentenyl monophosphate kinase (IMK) (Lange and Croteau 1999). 
Shikimate kinases have also been identified as a member of this kinase family 
(Daugherty, Vonstein et al. 2001) 
 
 
FIGURE 4.2: The conserved phosphate-binding-loop in classical p-loop-containing group of 
kinases family. The signature motif phosphate-binding-loop is highlighted by a red square. 
Sequence alignment using BioEdit (Hall 1999) and DALI (Holm and Sander 1993) server. 
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FIGURE 4.3: Structures of the classic GHMP kinase family enzymes. Helices and β-strands are 
shown as grey cylinders and arrows. The signature phosphate-binding-loop are shown in red. The 
r.m.s.d value between these structures is in a range of 2.2-3.0. These values are suggested by the 
web-based protein structure comparison service SSM at European Bioinformatics Institude (EBI) 
http://www.ebi.ac.uk/msd-srv/ssm/.  
4.2.3 Mevalonate Kinase from S. aureus  
Mevalonate kinase (MK) (E.C. 2.7.1.36) transfers the γ-phosphoryl group of ATP to 
the C5 hydroxyl oxygen group in mevalonate, converting mevalonate to mevalonate 
5-phosphate. The systematic name of mevalonate kinase is: ATP: mevalonate 
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5-phosphotransferase. Studies have suggested that this enzyme is essential for the 
biosynthesis of IPP in both the mevalonate-dependent (Goldstein and Brown 1990) 
and non-mevalonate pathway (Contin, van der Heijden et al. 1998; Schulte, van der 
Heijden et al. 2000). Mevalonate kinase was first discovered in 1950s (Amdur 1957; 
Tchen 1958). This enzyme has been found in eukaryotes (Goodman and Popjak 1960), 
archaeal sources (Williamson and Kekwick 1965), plants (Rogers, Shah et al. 1966) 
and animals including human (Soler, Jabalquinto et al. 1979; Porter 1985) where it 
plays an important role in all of these organisms. A deficiency of mevalonate kinase in 
human can lead to inherited diseases such as hyperimmunoglobulemia D syndrome 
(HIDS) and mevalonic aciduria (Houten, Wanders et al. 2000). S. aureus requires the 
mevalonate-dependent pathway to generate the basic building block IPP for 
isoprenoids biosynthesis (Kuroda, Kuroda et al. 2003). Although kinase is shared with 
humans, the generation of kinase inhibitors now in development as anticancer agents 
(Mani, Wang et al. 2000) holds out the hope of engineering specific targeted 
inhibitors.  
 
FIGURE 4.4: Reaction catalyzed by mevalonate kinse (E.C 2.7. 1. 36). With the conversion of 
ATP to ADP.  
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The mevalonate-dependent pathway is essential for survival of S. aureus on skin and 
nose mucosa (Peacock, de Silva et al. 2001; Voynova, Rios et al. 2004). S. aureus MK, 
in common with other bacterial enzymes, is much smaller than the eukaryotic MKs. 
Crystal structures of bacterial and animal MK such as the rat MK in complex with 
ATP has provided insights into how the eukaryote protein binds with the co-factor. 
However, there is no bacterial MK structure in complex with substrate and co-factor. 
S. aureus mevalonate kinase is up-regulated in strain MRSA252, but down-regulated 
in strain MSSA476, such proteomic differences suggesting that this enzyme may be 
particularly important for the pathogenic strain. In addition, the structural and 
functional differences between S. aureus MK and animal (human) MK might provide 
some novel ideas for inhibitors design. When the project began there was no 
prokaryotic ATP analogue co-complex structure known. 
4.3 Materials & Methods 
4.3.1 Over-expression and purification of MK  
IPTG induction and Auto-induction 
The small scale IPTG induction method was used to test solubility. The S. aureus 
mevalonate kinase plasmid was firstly transformed into E. coli BL21 (DE3) cells 
(Novagen) and plated onto Ampicillin agar plates. Single colonies were grown in 10 
ml LB medium at 37 ℃ for 4 hours, grown to an OD600 of 0.6–0.8 at 37 ℃, 
supplemented with 100 µg/ml ampicillin. The temperature was then reduced to 25 ℃ 
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and 16 ℃, respectively. Protein over-expression was achieved by induction with 1.0 
mM isopropyl β-D-1-thiogalactopyranoside (IPTG) for 6 hours.  
The auto-induction method was employed to test the expression and solubility 
(Studier 2005). 1ml of a 10 ml overnight culture was used to inoculate 50 ml of LB 
and the cells were harvested, after overnight incubation at 37 ℃, at 2000 g and 
re-suspended in 20 ml PBS. This was then used to inoculate auto-induction medium 
for over-night expression of protein, as detailed by Studier (Studier 2005). 500 ml of 
auto-induction growth medium in a 2L baffled flask, supplemented with 100 µg/ml 
ampicillin, was inoculated with 5 ml re-suspended cells and grown at 37 ℃, using 
shaking at 300 r.p.m for 4 hours to start bacterial growth. The temperature was then 
lowered to 16 ℃ and left for 48 hours to reach saturation (OD600 ~ 2.6). The results 
indicate that more soluble S. aureus MK resulting using the auto-induction method 
(FIGURE 4.5). Large scale (4 L) expression using auto induction was then performed 
to produce the target protein. Induced cells were harvested by centrifugation at 10500 
x g for 15 minutes (Beckman Avanti J20-XP, JL8.100 rotor). The cells were 
re-suspended in PBS to remove any excess growth media and stored at -80 ℃ until 
required. 
  153 
 
FIGURE 4.5: Coomassie Blue stained SDS-PAGE gels of S. aureus PFK. [A.1] protein marker. 
[A.2] crudes flow through of IPTG induction at 16 ℃.[A.3] first elution of IPTG induction at 
16 ℃. [A.4]crudes flow through of IPTG induction at 25 ℃. [A.5] first elution of IPTG 
induction at 25 ℃. [B.1] crudes flow through of auto induction at 16 ℃. [B.2] first elution from 
auto induction at 16 ℃. [B.3] first elution from auto induction at 25 ℃. [B.4] first elution from 
auto induction at 25 ℃. 
Purification 
A standard purification protocol was applied as described in chapter II. The buffer 
system for MK purification is slightly different from PFK protein. 50 mM phosphate 
buffer (11.25 mM NaH2PO4, 38.75 mM Na2HPO4) replaced the 50 mM Tris-HCl in S. 
aureus MK purification approach. The induced cells were re-suspended in binding 
buffer at room temperature for 30 minutes. The cells were disrupted by sonication for 
8 cycles of 45 seconds, interrupted by 1 minute periods on ice after addition of 
20µg/ml DNAse I and one tablet of protease inhibitor (ROCHE). To ensure that the 
DNA was digested by DNAse I, the mixture was kept at 4℃ for another 20 minutes. 
After addition of 2 mM EDTA, the mixture was centrifuged for 45 minutes at 105000 
x g at 4 ℃. Then the supernatant fraction was passed through a 0.22 µm syringe filter 
  154 
(Millipore) and collected for further purification. 
The supernatant containing mevalonate kinase protein was applied to a charged 
Histrap Nickel Sepharose, high performance column (Amersham Biosciences), which 
had been equilibrated already with binding buffer. Unbound and weakly bound 
proteins were removed by extensive washing with washing buffer. Essentially pure 
mevalonate kinase protein was eluted and collected with elution buffer. Eluted protein 
was incubated with 1 ml of 2 mg/ml tobacco etch virus protease (TEV) (approximate 
ratio 20:1 protein: protease) to remove the polyhistidine tag at room temperature 
(25 ℃). The MK protein and TEV mixture was dialyzed against 500 mM NaCl, 2 mM 
DTT, 50 mM phosphate buffer, pH 8.0 and 10% glycerol for 6 hours to remove 
imidazole. The progress of cleavage was checked by sodium dodecyl sulphate 
polyacrylamide gel electrophoresis (SDS-PAGE) (FIGURE 4.6).  
 
FIGURE 4.6: Coomassie Blue stained SDS-PAGE gels of S. aureus MK. [A.1] protein marker. 
[A.2] crudes flow through. [A.3] first wash through. [A.4]first elution. [A.5] second elution. 
[B.1]protein marker. [B.2]before tev cleavage. [B.3] 2 hours after addition of tev. [B.4]6 hours 
after addition of tev. [B.5] elution from second nickel column. 
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The protein-TEV mixture was passed through a 0.22 μM syringe filter membrane 
(Millipore) and a second Ni-NTA column to remove any non-cleaved protein, tag and 
protease (Liu and Naismith 2005). Then the flow through was concentrated to 
approximately 5 mL before further purification by size exclusion gel filtration. Some 
precipitant was removed by centrifugation at 75000 x g for 10 min (4℃, Beckman 
Avanti J20-XP JA25.50 rotor). Size exclusion gel filtration was applied on a 
Superdex™ 200 size exclusion chromatography column (Amersham Biosciences) 
After the gel-filtration step proteins were judged to be pure by Coomassie™ 
Blue-stained gels and their integrity was confirmed by mass spectrometry (University 
of St Andrews) (FIGURE 4.7). In total it was estimated 20 mg pure S. aureus 
mevalonate kinase native protein was obtained from 4 L of cell culture. According to 
the results of the Pre-Crystallization Test (PCT), the protein was then concentrated to 
10 mg/ml and 5 mg/ml respectively prior to crystallization. Some of the protein was 
flash-frozen in liquid nitrogen for long term storage. The buffers used in each step 
were summarized in TABLE 4.1 
 
Binding buffer 
500 mM NaCl, 2 mM DTT, 50 mM phosphate buffer, pH 8.0, 
(11.25 mM NaH2PO4, 38.75 mM Na2HPO4), 10 mM imidazole  
Wash buffer 
500 mM NaCl, 2 mM DTT, 50 mM phosphate buffer, pH 8.0, 
(11.25 mM NaH2PO4, 38.75 mM Na2HPO4), 35 mM imidazole 
Elution buffer 
500 mM NaCl, 2 mM DTT, 50 mM phosphate buffer, pH 8.0, 
(11.25 mM NaH2PO4, 38.75 mM Na2HPO4), 500 mM imidazole 
Dialysis buffer  
500 mM NaCl, 2 mM DTT, 50 mM phosphate, pH 8.0, (11.25 mM 
NaH2PO4, 38.75 mM Na2HPO4), 500 mM imidazole, 10% glycerol. 
1mM EDTA 
Gel-filtration buffer 
(Crystallization buffer) 
150 mM NaCl, 50 mM phosphate buffer (11.25 mM NaH2PO4, 
38.75 mM Na2HPO4), pH 8.0 
TABLE 4.1 Buffers used in each step of S. aureus MK purification.  
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FIGURE 4.7: Gel-filtration results and mass spectrometry analysis of S. aureus mevalonate 
kinase. [A] selected fraction of gel-filtration elution. [B] mass spectrometry output of the protein.  
4.3.2 Crystallization and optimization of MK crystals 
The substrate of MK, (R)-Mevalonate was not commercially available, so 
mevalonatelactone purchased from Sigma-Aldrich was purchased to prepare 
mevalonate according to the protocol described in (Skilleter and Kekwick 1967). A 
standard stock solution was prepared by using 1g of Mevalonatelactone (SIGMA, 
MW: 130) added to 4.62ml of 1M NaOH, the solution were incubated at 37 ℃ for 2 
hours to hydrolyze the mevalonolactone, the pH was adjusted to 7.2 with HCl and the 
final volume was brought to 7.69ml with distilled water.  
 
FIGURE 4.8: Mevalonolactone hydrolysised by NaOH and converted to mevalonate. 
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In order to produce complex crystals of mevalonate kinase with its substrate and 
co-factor, co-crystallization method was attempted using 20 mM substrate mevalonate 
and 10 mM AMP-PNP. AMP-PNP is an analogue of ATP, and it resistant to hydrolysis 
because th e O between γ- and β-phosphate is replaced by N. Mevalonate and 
AMP-PNP were both dissolved in mevalonate kinase crystallization buffer to avoid 
any disruption to the protein solution. The protein and ligands solution were mixed 
gently and pre-incubated for 6 hours at 4°. The protein and ligands mixture was then 
centrifuged at 35000 x g for 2 min (Eppendorf Centrifuge 5415D) to remove any 
insoluble compounds and precipitated protein.  
 
The sitting drop method was employed for crystal screening, using a drop size of 0.3 
μl, containing 0.15 μl proteins and 0.15 μl precipitant, against 80μl screen buffer. The 
same nano-drop crystallization robot (Cartesian Honeybee) from Hamilton-Thermo 
Rhombix system was also used to perform this screening. The crystal screens 
employed for this initial crystal screening including JMac, Nextal-The Classics, 
Nextal-JCSG, Nextal-PEGs (Hampton Research). All the sitting drop trials were kept 
in a quiet room at 20 ℃ for crystal growing. The best crystals judged by shape and 
size appeared after approximately 5 days from Hampton PHClear condition 19 [0.1 M 
citric acid pH 4.0, 4 M sodium chloride]. An optimization screen around this 
condition was attempted to produce better quality crystals suitable for X-ray 
diffraction. Some large crystals were observed in an optimized condition containing 
0.1 M Citric acid, pH 3.8, 3.6 M NaCl. Using a drop with 3 µL protein and 3µL 
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precipitant equilibrated against a reservoir of 100 µL optimized screen buffer. 
Crystallization conditions had to be translated and optimized from nanodrop to 
microliter drop size. The best results were obtained using sitting drop plates 
(Hampton Research CrystalClear Strips™ 96 wells plates) with 2 µl MK protein plus 
2 µl precipitant. Changing of the NaCl concentration from 3 M to 4 M did not change 
the form of the crystal, and the crystals grew to typically 0.1 to 0.3 mm in the longest 
dimension. The diffraction quality was tested by an in house X-ray generator, Crystals 
were cryo-protected with 20% – 25% glycerol added to screen buffer before being 
flash-frozen for synchrotron source data collection before being flash-frozen for 
synchrotron source data collection. The improvement of the size and quality of the 
crystals can be seen in FIGURE 4.9 
 
 
FIGURE 4.9: S. aureus MK crystals. [A] S. aureus MK complex crystals grown in nano drop. [B] 
Larger crystals of S. aureus MK complex after optimization at similar condition. 
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4.3.3 Data collection and initial processing 
Crystals were cryo-cooled in liquid nitrogen using a cryo-protectant of screen buffer 
containing 20% glycerol, 0.1 M Citric acid, pH 3.8, 3.6 M NaCl. A dataset diffracting 
to 2.2 Å was collected on crystals at ESRF Beamline BM14. 308 images were 
collected using an exposure time of 20 seconds and a crystal to detector distance of 
225.9 mm. The wavelength used for data collection is 0.953 Å. The data set was first 
indexed with the program DENZO (Otwinowski and Minor 1997). The suggested 
crystal lattice belonged to a primitive hexagonal Laue group with cell dimensions of 
a=b= 94.6 Å, c=169.0 Å; α=β= 90° γ=120°. Data were integrated with these 
parameters and then merged in SCALEPACK (Otwinowski and Minor 1997). 
Diffraction image and data collection statistics are shown in FIGURE 4.10 and 
TABLE 4.2 respectively. 
 
 
FIGURE 4.10: X-ray diffraction pattern of S. aureus MK crystals from beamline BM14 ESRF. 
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The resolution at the edge of the detector is 2.0 Å. 
Data collection S. aureus mevalonate kinase 
Wavelength  (Å) 0.953 
Resolution (Highset Shell) 81.92 – 2.20 (2.26-2.20) 
Unit cell 
a=b=94.589., c=169.010 
α=β=90, γ=120 
Space Group P6222 
Unique reflections 17784 (1937) 
Average redundancy 4.6 (4.2) 
Completeness (%) 100 (78.3) 
Rmerge 0.095 (0.34) 
I/σ (I)/ 17.7 (4.7) 
TABLE 4.2: Summary of data collection statistics for S. aureus MK crystal collected in ESRF. 
4.3.4 MR attempts and heavy atom soaking. 
Attempts to solved the structure by Molecular Replacement were made with AMoRe 
(Navaza 1994), MOLREP (Vagin and Teplyakov 2000) and PHASER from CCP4 
suite using crystal structure of L. major mevalonate kinase (PDB entry: 2HFU) 
(Sgraja, Smith et al. 2007). However these attempts ultimately proved unsuccessful, 
the programs only giving a partial solution with a Rotation Function Z of 4.3. This 
may have been due to the limited sequence identities with the potential search models 
(highest sequence identity was 29%).  
Since the structure could not be solved by molecular replacement we tried to use other 
techniques to solve the structure including the use of heavy atom. Several heavy metal 
salts were selected by signal strength at 1.541 Å in an attempt to obtain derivative 
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crystals (FIGURE 4.8), including pCMBS, Hg(NO3)2, K2Hg(NO3)4, Au[CN]2, 
Sm(NO3)3 and K2Pt[CN]4. The apo-form crystals was transferred to “heavy atom 
soaking solution” containing cryo-protectant of 25% glycerol, 0.1 M Citric acid, pH 
3.8, 3.6 M NaCl, and 2-20 mM heavy metal derivatives for a short time (10 min) or a 
long time (overnight) to assessed for stability. Crystals usually tolerated soaking, 
however in some cases the crystals began to dissolve in the solution, or cracked. 
Crystals that survived soaking using low concentration (2 mM) were also soaked 
using a higher concentration (20 mM). Those crystals that survived were assessed for 
X-ray diffraction. The in-house Rigaku-MSC Micromax-007 hf X-RAY generator 
system (λ=1.541Å) was used to collect these heavy atom data, the oscillation angle 
was 0.5 degree from -180° to 180° and the distance between the crystal to detector 
was 70 mm. At this stage, 6 heavy atom datasets were collected. 
 
 
FIGURE 4.11: Plot of theoretical f’ and f’’ for different heavy atoms under different X-ray 
wavelength. Image was made by a web-based X-ray Anomalous Scattering Coefficients check tool 
http://skuld.bmsc.washington.edu/scatter/ 
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4.3.5 Data processing, structure solution and model refinement 
For the multiple isomorphorus replacement (MIR) attempts, the phase calculations 
and heavy atom sites localization were performed with the PHENIX program (Adams, 
Grosse-Kunstleve et al. 2002) using two heavy atom soaking datasets combinations. 
However, most of the electron density maps generated from those heavy atoms were 
ambiguous and difficult to interrupt, possibly due to non-isomorphism between the 
datasets. However a Sm(NO3)3 and a K2Pt[CN]4 dataset collected to 2.6 Å and 2.7 Å, 
respectively, were able to localize 2 heavy atom sites using PHENIX. The AutoBuild 
program in PHENIX suite then significantly improved the initial phases and a partial 
model was built with 223 residues. Although this model was incomplete, it still 
showed a GHMP kinase family basic overall fold (FIGURE 4.12).   
 
Data collection MK-Sm MK-Pt 
Wavelength  (Å) 1.541 1.541 
Resolution (Highset Shell) 30 – 2.60 (2.65-2.60) 30-2.70 (2.74-2.70) 
Unit cell 
a=b=94.10., c=169.10 
α=β=90, γ=120 
a=b=94.00., c=168.90 
α=β=90, γ=120 
Space Group P6222 P6222 
Unique reflections 34293 (4937) 35120 (4968) 
Average redundancy 5.6 (4.2) 5.9 (4.3) 
Completeness (%) 100 (78.3) 98 (80.6) 
Rmerge 0.095 (0.34) 0.095 (0.43) 
I/σ (I) 17.7 (3.7) 19.7 (3.9) 
TABLE 4.3: Summary of data collection statistics for heavy atom soaked MK crystals. 
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FIGURE 4.12: Cartoon representation of the model build by Autobuild in PHENIX suite. 212 
residues were build in this model with an initial R/Rfree = 0.37/0.42. 
The ARP/wARP program was then used to auto build the initial mevalonate kinase  
model with the MTZ file generated from program PHENIX and the mevalonate 
kinase sequence file of 306 amino acids. 9 chains of 269 residues in total were built in 
the new model after 50 building cycles with an R factor/R free of 0.31/0.38. Although 
there were 37 amino acid residues still missing in this new model, it was possible to 
rebuild the model manually using WinCoot and REFMAC5 subsequently. 
“Translation, libration and screw rotation parameters” (TLS) (Potterton, Briggs et al. 
2003; Winn, Murshudov et al. 2003) was used in model refinement. Water molecules 
were added to the model automatically using ARP/wARP (Perrakis, Morris et al. 1999) 
in CCP4 program suite. Ligand libraries were prepared using PRODRG (Schuttelkopf 
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and van Aalten 2004). The MK model refinement statistics are summarized in TABLE 
4.4. 
Refinement S. aureus MK 
Clashscore (percentage) 8.84 (92%) 
Rotamer outliers (%) 0.85 
Cβ deviations >0.25 Å 0 
Residues with bad bonds/angles (%) 0.00 
MolProbity Score (percentage) 1.49 (99%) 
Ramachandran favoured/outliers (%) 97.92/0.69 
R factor 0.213 
R free 0.257 
r.m.s.d bond lengths(Å)/angles 0.008/1.070 
TABLE 4.4: Model refinement and validation statistics of S. aureus MK 
4.3.6 S. aureus MK enzyme activity assay 
S. aureus mevalonate kinase enzyme activity assay was based on that previously 
described by Porter (Porter 1985) with some modification and carried out. The 
enzyme activity was measured by coupling the formation of ADP to the oxidation of 
NADH via two related enzymes, lactate dehydrogenase (LDH) and pyruvate kinase 
(PK), determined by measuring the decrease of absorbance at 340 nm using a 
spectrometer at room temperature (25 ℃). 
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FIGURE 4.13: reactions in the measurement of mevalonate kinase enzyme activity using the 
coupled assay with pyruvate kinase (PK) and lactate dehydrogenase (LDH).  
 
FIGURE 4.14: Diagram of the coupled reaction of formation of mevalonate 5-phosphate and 
ADP to the oxidation of NADH via two related enzymes, lactate dehydrogenase (LDH) and 
pyruvate kinase (PK). 
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The reaction mixture for this coupled assay containing 50 mM potassium phosphate 
buffer (KH2PO4/K2HPO4), pH 7.5, 0.2 mM NADH, 4 mM ATP, 8 mM MgCl2, 1 mM 
phosphoenolpyruvate (PEP), 35 units pyruvate kinase, 55 units lactate dehydrogenase 
and 2 mM mevalonate. The final volume of the reaction mixture was 1 ml. The 
mixture was mixed gently and the background rate for the oxidation of NADH was 
measured for 3 minutes before addition of MK. The reaction was monitored for an 
additional 60 seconds. A unit enzyme activity is defined as the amount of enzyme 
producing 1 µmol mevalonate 5-phosphate per minute. All coupling enzymes and 
chemicals were tested in absence to make sure that the rate of the standard assay is not 
limited by them. All the reagents and assays auxiliary enzymes were purchased from 
Sigma-Aldrich.  
 
The Km for mevalonate was determined using an enzymes assay mixture containing 4 
mM ATP, mevalonate concentration between 0.01 – 2 mM, and 1µg of pure S. aureus 
MK. Three repeat measurements were carried out to make sure the data are consistent. 
Data replotted in Grafit graphic analysis program. Km of S. aureus MK for mevalonate 
was obtained using the Michaelis – Menten equation.   
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FIGURE 4.15: Enzyme kinetics study on S. aureus MK. The apparent Km of S. aureus MK for 
mevalonate was approximately 110 µM when enzyme was measured in the presence of 4 mM ATP 
and 8 mM MgCl2.  
4.3.7 Thermofluor study on S. aureus MK 
The Thermofluor assay is also applied for finding the potential hits for S. aureus MK. 
The same sample preparation and assay protocol are employed as described before 
(Chapter 2.3.6). All the samples were repeated twice at the same condition. The 
melting curves were also generated by the program iCycler iQ Optical System. The 
data could be further processed using the same program and Origin. Those fragments 
that shifted Tm over 2 ℃ were classed as hits.  
 
Fragments Structure Formula ΔTm (℃) 
2-methyl-3-furoic acid 
O
O
OH
CH3   
C6 H6 O3 3 
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3-(2-methoxyphenyl)propanoic acid 
O
OH
O
CH3   
C10 H12 O3 2 
3-(2-hydroxyphenyl)propanoic acid 
O
OH
OH  
C9 H10 O3 2 
1-methyl-5-(trifluoromethyl)-1H-pyrazol
-3-ol N
N
F
F
F
OH
CH3   
C5 H5 F3 N2 O 2 
3-oxoindane-1-carboxylic acid 
N
O OH
F
CH3  
C10 H8 O3 2 
2-ethyl-6-methylpyridine 
NCH3
CH3
 
C8 H11 N 3 
4-hydroxy-1-methyl-1,2-dihydroquinolin
-2-one N O
OH
CH3  
C10 H9 N O2 3 
2,5-dimethyl-3-furoic acid 
O
O
OH
CH3CH3  
C7 H8 O3 2 
2-furoic acid N
O
NH2
CH3  
C5 H4 O3 3 
benzo[b]furan-3-ylacetic acid N N
OH
 
C10 H8 O3 3 
1-methyl-1H-indole-6-carboxylic acid N
O
OH
CH3  
C10 H9 N O2 4 
2-(benzylthio)acetic acid 
O
S
OH
 
C9 H10 O2 S 2 
2-hydroxy-2-phenylacetic acid 
O
OH
OH  
C8 H8 O3 3 
2-(1,3-benzothiazol-2-yl)acetonitrile N
S
N
  
C9 H6 N2 S 3 
2-fluoro-4-hydroxybenzonitrile 
N
FOH  
C7 H4 F N O 3 
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3-chloro-4-fluorophenol 
N
O
OH
CH3
CH3
 
C6 H4 Cl F O 2 
2-fluorobenzoic acid 
O
OH
F  
C7 H5 F O2 3 
2-(2-hydroxyphenyl)acetic acid 
O
OH
OH  
C8 H8 O3 3 
D-proline 
N
O
OH
H  
C5 H9 N O2 4 
TABLE 4.5: The positive hits of the thermal shift assay 
These potential hits all are aromatic hetrocycles and possibly mimic the adenosine 
group. This mimicry is often seen in kinase type inhibitors (Ramdas and Budde 1998).  
 
4.4 Results & Discussion 
4.4.1 Crystal structure of S. aureus MK 
Monomer 
The crystal structure of S. aureus MK was determined to 2.20 Å. The final refined 
model of S. aureus MK monomer contains 295 residues with an Rfactor and Rfree of 
0.21/0.26. The monomer appears as a bell-shape with two distinct structural domains. 
There are 11 β-strands and 9 α-helices in the final refined model. 
The N-terminal domain is composed of residues 2-168, comprising the first seven 
β-strands (β1-β7) and four α-helices (α1-α4). The outer side of the large β-strands β1, 
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β3-β5 is mostly exposed to the solvent. The C-terminal domain is formed by residues 
169-306 and contains four β-strands (β8-11) and five α-helices (α5-9). The four 
anti-parallel β-sheets β8-β10 are sandwiched by helices α5, α6 α7 and α8. The 
electron density of residues 182-183, 191-198 that located between helix α5 and 
strand β8 is weak. These residues lie at the surface of the S. aureus MK molecule. 
There is a deep cleft between the N- and C-terminal domains, and this cleft is 
predicted to contain mevalonate binding, ATP binding and catalytic site (FIGURE 
4.16). The predicted ATP binding site has a strong positive charge (FIGURE 4.17). A 
citric acid molecule is bound in this cleft, presumably from the crystallization 
condition. (Chapter 4.4.2). 
 
FIGURE 4.16: Cartoon representation of S. aureus mevalonate kinase monomer. Helices are 
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shown in orange and labeled, β-sheets in large domain are colored in green and loops are shown 
in blue. 
 
FIGURE 4.17: The surface electrostatics potential of S. aureus mevalonate kinase. The 
solvent-accessible surface of MK colored based on the electrostatics potential from -7 to +7 kT/e, 
calculated using ABPS tools in PyMol™. Positive charge is shown in blue and negative charge is 
shown in red. 
The overall sequence similarity within the GHMP kinase family is low. An 
examination of the Protein Data Bank (PDB) for similar structures using the 
web-based protein structure comparison service SSM at European Bioinformatics 
Institute (EBI) http://www.ebi.ac.uk/msd-srv/ssm/ (Krissinel and Henrick 2004) 
shows that the S. aureus MK still shares a common overall fold with other GHMP 
kinase family enzymes with a r.m.s.d range of 2.5 – 4.2 Å. The locations of active site 
for mevalonate and ATP binding are likely to be conserved across the GHMP kinase 
family. The overall structure fold of S. aureus MK is more close to bacterial and L. 
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major (r.m.s.d of Cα atoms 2.5-3.5 Å) rather than mammalian enzymes (r.m.s.d 
3.7-4.2 Å) (TABLE 4.6 and FIGURE 4.18) 
Source Nalign r.m.s.d(Å) 
L. major mevalonate kinase 265 2.77 
S. pneumonia mevalonate kinase 238 3.21 
Rat mevalonate kinase 210 4.27 
Human mevalonate kinase 189 3.72 
P. horikoshii galactokinase 238 2.82 
M. jannaschii homoserine kinase 233 3.29 
S. pneumonia phosphomevalonate kinase 242 3.51 
TABLE 4.6: Structure alignment of S. aureus mevalonate kinase using SSM at European 
Bioinformatics Institude (EBI) http://www.ebi.ac.uk/msd-srv/ssm/ (Krissinel and Henrick 2004). 
Nalign indicates the Cα atoms aligned.  
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FIGURE 4.18: Ribbon view of the GHMP kinase family members’ structures. MK from S. aureus 
(PDB code: 2X7I), MK from L. major (PDB code: 2HFS), galactokinase from P. horikoshii (PDB 
code: 2DEJ) homoserine kinase from M. jannaschii (PDB code: 1FWK) and phosphomevalote 
kinase from S. pneumoniae (PDB code: 1K74)  
Structure comparison between these enzymes shows that they all comprise two 
domains. The N-terminal domain of the GHMP kinase family enzymes is mainly 
responsible for ATP binding and also participates in the formation of the catalytic 
centre in the GHMP kinase family (Zhou, Daugherty et al. 2000; Fu, Wang et al. 
2002). The C-terminal domain in the GHMP kinase family enzymes is considered as 
the substrate binding domain (Zhou, Daugherty et al. 2000; Romanowski, Bonanno et 
al. 2002). There are some differences in some structure elements between S. aureus 
MK and other members of the GHMP kinase family. Some other GHMP kinases have 
more residues compare with S. aureus MK (306 residues), such as human MK (396 
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residues), rat MK (394 residues) and P. horikoshii galactokinase (346 residues). These 
additional residues form some extra structural elements in the N-terminal domain.  
In rat MK, the sequence insertion forms a strand and a short helix. These additional 
structural elements create an open cavity that leads to the phosphate-binding-loop 
(motif II) and contributes to the binding of adenosine moiety of ATP. In S. aureus MK 
model, strand β4 is followed by a tight turn (loop) that links to helix α1 (residues 
57-68). As a result the loop lies across the surface of the phosphate-binding-loop, 
which is the predicted ATP binding cavity. This loop denoted the “adenosine strap 
loop” could restrict the access of ATP/AMP-PNP by hindering the binding of 
adenosine group of ATP/AMP-PNP (FIGURE 4.19). 
 
FIGURE 4.19: Cα-trace structure alignment of the N-terminal domains of the S. aureus MK and 
Rat MK. The S. aureus MK structure is shown in blue, the Rat MK is shown in orange. ATP 
molecule from Rat MK is superimposed to indicate the potential ATP binding site. N atoms, O 
and P atoms are shown in blue, red and orange, respectively. The related secondary structure 
elements of S. aureus MK are labeled. 
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Mammalian MKs (e.g. human MK) (Fu, Voynova et al. 2008) appear to conserve the 
insertion, presumably the same open binding cavity as rat MK. Some bacteria MKs 
also have sequence insertion in the N-terminal domain such as the M. jannaschii MK  
(Yang, Shipman et al. 2002). Currently the “adenosine strap loop” is only observed in 
a few bacteria enzymes of the GHMP kinase family such as S. aureus MK and M. 
jannaschii homoserine kinase (Zhou, Daugherty et al. 2000). MK from Leishmania 
major (Sgraja, Smith et al. 2007) exhibits this “adenosine strap loop” as well. No ATP 
or other ATP analogs complex structures were reported for these enzymes with the 
“adenosine strap loop”. Attempts to obtain such complex structures with 
ATP/AMP-PNP binding were unsuccessful (Zhou, Daugherty et al. 2000; Sgraja, 
Smith et al. 2007). It seems that the ATP binding in these “adenosine strap loop” 
group MKs is more difficult than the other MKs with sequence insertion, which forms 
the open active site. Although this “adenosine strap loop” seems to block the access to 
ATP binding cavity, the enzyme assay shows that S. aureus MK is functional 
performing the phosphorylation reaction. Because this loop is located at the surface of 
the protein, we predict that the conformation of this loop could be influenced by 
crystal packing.  
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FIGURE 4.20: Cα-trace overlay for the N-terminal domains of S. aureus MK and other members 
of the GHMP kinase family. [A] S. aureus MK (blue) and Human MK (green). [B] S. aureus MK 
(blue) and L. major MK (grey).  
A multiple sequence alignment of MKs from different species and S. aureus MK 
indicates that there are three conserved structural motifs in MKs and other members 
of the GHMP kinase family (e.g. galactokinase from Pyrococcus furiosus). The 
conserved structural motif I of the GHMP kinase family, in S. aureus MK, comprises 
the last part of strand β1 and the loop link to β2, including residues 11-20. This motif 
usually has the sequence of Lys-Ile/Val-Ile-Leu-X-Gly-Glu-His (Yang, Shipman et al. 
2002). As a part of the N-terminal domain, motif I mainly contributes to the formation 
of active site and interacts with the substrate (Zhou, Daugherty et al. 2000; 
Romanowski, Bonanno et al. 2002). Motif II locates at the edge of N-terminal domain, 
close to motif I, has an invariant residue arrangement of Gly-X-Gly-Ser-Ser-Gly-Ala 
(residues 98-106 in S. aureus MK). These residues compose the loop after β5 and the 
initial part of helix α2. This β-turn-α motif is the signature structural motif 
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“phosphate-binding-loop” that interacts with the β- and α- phosphate groups of ATP in  
the GHMP kinase family (Bork, Sander et al. 1993). Motif III is formed by part of β8 
and the loop which connects to β9, and has a sequence of 
Lys-Leu-Thr/Ser-Gly-X-Gly-X-Gly-Gly residues order (residues 266-274 in S. aureus 
MK). This motif is considered to stabilize the phosphate binding loop (Zhou, 
Daugherty et al. 2000).  
 
FIGURE 4.21: structure-based sequence alignment of Mevalonate kinases and galactokinase 
from the GHMP family. The mevalonate kinase sequences from S. aureus (MK_Sa), Streptococcus. 
pneumoniae (MK_Sp), Methanocaldococcus. jannaschii (MK_Mj) Leishmania. Major (MK_Lm) 
and galactokinase from Pyrococcu. furiosus (GK_Pf). Identical residues in the sequences aligned 
are highlight in black, residues shaded grey indicate regions of sequence homology. The three 
conserved motifs are highlighted in red box.  
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FIGURE 4.22: stereo view of the three conserved GHMP kinase family structure motifs in 
S.aureus mevalonate kinase. Motif I is shown in purple, motif II and III are shown in green and 
blue, respectively. The related strands and helices are labeled for clarity.   
Some conformational changes around the predicted active site were observed around 
the substrate binding site of S. aureus MK when superimposed with other MKs. The 
main difference is the conformation of motif I. In other structures, this motif appears 
as a short helix, ~12 Å from motif II. In S. aureus MK, these two motifs are ~6 Å 
apart. Motif III in S. aureus MK is closer to motif I and the distance from motif I is 
about ~ 5 Å. These major changes in S. aureus MK is probably due to the binding of 
citric acid. However, the conformational changes in the three loops appear to be 
coupled, if one or two of the three loops were to adopt the conformation seen in other 
structures, residues would clash. It seems that the loops adopt one arrangement or the 
other. This coupling of structural movements may be significant as these loops from 
the binding site.  
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FIGURE 4.23: ribbon view of superimposed mevalonte kinases family members and S. aureus 
MK. The S. aureus MK is shown in blue, L. major MK in grey, human MK in green and Rat MK 
in orange. The three conserved motifs are labeled in black and main conformational changes in S. 
aureus MK are labeled by red arabic numbers 1, 2 and 3. The possible original conformation for 
the conformational changes 1, 2 and 3 are indicated by (a), (b) and (c), respectively.  
The web-based analysis tool PISA “protein interfaces, surfaces and assemblies” 
http://www.ebi.ac.uk/msd-srv/prot_int/pistart.html (Krissinel and Henrick 2005) was 
used to analysis the crystal packing of S. aureus MK. The results indicate that S. 
aureus MK is stable as both dimer and tetramer form. The dimer form is consistent 
with the gel-filtration result which suggested that the S. aureus MK is a stable dimer 
in solution form. The fact that PISA predicts a tetramer may be a function of crystal 
packing. 
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FIGURE 4.24: Analysis output of S. aureus MK structure by PISA server. 
In the dimer form, the two subunits of the dimmer are related by crystallographic 
symmetry and associate with each other via the interactions between their N-terminal 
domain, α1, β4 and the loop (adenosine strap loop) between them are the main 
structural elements that participated in monomer-monomer interactions. An interface 
area of ~3300 Å2 is buried between the two monomers. The dimer form of S. aureus 
MK is shown in FIGURE 4.25. The β4 from each subunit interacts with each other 
and extend the anti-parallel β-sheets conformation. While the α1 and adenosine strap 
loop from unit A interacts with the adenosine strap loop and α1 from subunit B, 
respectively. Notably the distance between α1/A and adenosine strap loop/B (α1/B 
and adenosine strap loop/A) are close (~4.8 Å), we predict that the interaction 
between this two elements may leads to a conformational change on adenosine strap 
loop and recesses to accommodate the ATP molecules. (FIGURE 4.26) 
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FIGURE 4.25: Surface electrostatics potential of S. aureus MK dimer suggested by PISA program. 
The solvent-accessible surface colored based on the electrostatics potential from -7 to +7 kT/e, 
calculated using ABPS tools in PyMol™. Positive charge is shown in blue and negative charge is 
shown in red. 
 
FIGURE 4.26: Cartoon representation of a close look of the dimer interface of S. aureus MK. The 
adenosine strap loop is highlighted in red, the phosphate-binding-loop is shown in green and 
labeled as “P-binding loop”. ATP molecules are superimposed to indicate the predicted binding 
site. 
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The tetramer can be thought of a dimmers of dimmers. In FIGURE 4.27 the dimers 
are AB and CD. The AB (CD) interface buries about 12100 Å2 areas by each other. 
The four subunits in the tetramer are related by crystallographic symmetry and 
associate with each other via the interactions between with the β-strands β7 and β4 
and form an extended and linked β-sheet area. The tetramer appears as a “hollow 
barrel” shape, surrounding by anti-parallel β-sheets in a row. The hole in the centre is 
about 15 Å wide. The active sites of each monomer are located at the surface of the 
hole inside the barrel. The hole is considered to be the entry point for substrate and 
ATP. The tetramer form suggested by PISA is shown in FIGURE 4.27.  
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FIGURE 4.27: Cartoon representation and Surface electrostatics potential of S. aureus MK 
tetramer. The solvent-accessible surface colored based on the electrostatics potential from -7 to 
+7 kT/e, calculated using ABPS tools in PyMol™. Positive charge is shown in blue and negative 
charge is shown in red. 
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4.4.2 The proposed active site and citric acid binding.  
The predicted ATP binding site of S. aureus MK locates in the cleft between the 
N-terminal and C-terminal domain. The signature motif II (phosphate-binding-loop), 
along with the adjacent helix α2 and β5, forms a deep cavity in the protein surface. 
The surface electrostatics potential shows this groove is strongly positively charged, 
consistent with ATP binding. (FIGURE 4.28) 
 
 
FIGURE 4.28: Cartoon representation and surface electrostatics potential of the phosphate 
binding loop of S. aureus MK. [A] Cartoon representation of the conserved signature structure 
motif of the GHMP kinase family, phosphate-binding-loop. The loop is shown in green. [B] 
Surface electrostatics potential of the phosphate-binding-loop in S. aureus MK. The 
solvent-accessible surface colored based on the electrostatics potential from -7 to +7 kT/e, 
calculated using ABPS tools in PyMol™. Positive charge is shown in blue and negative charge is 
shown in red. 
A citric acid molecule is bound in the “phosphate-binding cavity”, about 2.8 Å and 
3.2 Å from the amide chain of Gly98 and Gly100, about 3.0 Å from the side chain of 
Ser101and Ser102 (FIGURE 4.30). These four residues from the motif II and helix α2 
are highly conserved among MK family. The C3 hydroxyl group and C6 carboxyl 
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group of the citric acid form hydrogen bonds with these four residues. Ser96 bonds to 
the C5 hydroxyl group of citric acid. Asp63 from the loop between β4 and helix α1 
also hydrogen bond to the C5 carboxyl group. His19 and Ala20 from motif I both 
interact with the citric acid molecule via a water-mediated network. Residues Lys12 
from β1 and Asp145 from α3 pointing to the C1 carboxyl group of citric acid and 
form a water-mediated network, these two residues are highly conserved in MKs and 
considered as the key catalytic residues (Voynova, Rios et al. 2004). (FIGURE 4.29). 
Water molecules surrounding the citric acid, indicating the cavity is a highly 
hydrophilic environment. This positive-charged and hydrophilic cavity is ideal for the 
phosphate donor of ATP binding. 
 
 
FIGURE 4.29: The conserved structure motif II of the GHMP kinase family. Identical residues in 
the sequences aligned are highlight in black. The red boxes indicate the highly conserved motif in 
MKs. This alignment was generated with BioEdit program. 
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FIGURE 4.30: Stereo view of key interactions of protein with citric acid. Protein residues are 
shown in green, citric acid in green and blue, and water molecules as red sphere. Hydrogen bonds 
are depicted as black dashed lines. Residues that might interact with the ligand are labeled in 
black letters. 
 
 
FIGURE 4.31: Surface electrostatics potential of the citric acid binding of S. aureus MK. The 
solvent-accessible surface colored based on the electrostatics potential from -7 to +7 kT/e, 
calculated using ABPS tools in PyMol™. Positive charge is shown in blue and negative charge is 
shown in red.  
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Our attempts to obtain a complex structure of S. aureus MK with ATP or  AMP-PNP 
(ATP analog) have been unsuccessful. This is probably due to the binding of citrate 
which both blocks the binding site and alters the structure. In order to investigate the 
binding mode and interactions between protein and co-factor, the ATP molecule was 
docked into the predicted binding site by superimposing the rat MK/ATP complex 
crystal structure with S. aureus MK structure.  
The adenine group is anti with respect to the ribose group, and the ribose group is 
binding with the residues Asn104 and Ser108 in Rat MK with reasonable distances 
(2.6 Å and 2.8 Å, respectively). In the S. aureus MK monomer, the modeled ATP 
clashes with the residues from the “adenosine strap loop” which presumably has 
prevented binding in our experiments 
 
FIGURE 4.32: Cartoon representation of the phosphate-binding-loop motif of Rat MK and S. 
aureus MK. [A] Cartoon representation of the ATP binding at the phosphate-binding-loop of Rat 
MK, the insert structure elements are labeled. [B] Cartoon representation of the superimposed 
ATP at the phosphate-binding-loop of S. aureus MK. The barrier loop and predicted clash are 
labeled. 
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FIGURE 4.33: Stereo view of superimposed phosphate-binding-loop of Rat MK and S. aureus 
MK. The two residues which interacts with the ribose group are labeled. The Rat MK is shown in 
grey, the S. aureus MK is shown in blue, the ATP molecule is superimposed to indicated the 
predicted biding site. 
Although the conformation of adenosine binding pockets are distinct due the 
additional insertion sequences in rat MK, the conformation of phosphate binding site 
is almost identical. In rat MK/ATP complex structure, the tri-phosphate interacts with 
the conserved motif II. The α-phosphoryl group of ATP hydrogen bonds to His197 
and indirect interacts with Gly140 via a water-mediated network. The β- and 
γ-phosphoryl group of  ATP coordinates an Mg2+-water network using residues Gly140, 
Gly 144, Ser145, Ser146 and Asp204 the side chain of Lys13 and Asp204 point 
towards the γ-phosphoryl group.  
In S. aureus mevalonate kinase/ATP model, these interactions are similar. The 
phosphate group binding residues are conserved; Gly140, Gly144, Ser145, Ser146, 
Asp204 and Lys13 in rat MK match Gly99, Gly100, Ser101, Ser102, Asp145 and 
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Lys12 in S. aureus MK. The strictly conserved residues Lys12 and Asp145 which 
close to the modeled γ-phosphoryl group (<2.8 Å) are predicted to be the key catalytic 
residues.  
 
FIGURE 4.34: Stereo view of the cartoon representation of the potential triphosphate moiety 
interaction with protein. [A] A stereo view the conserved phosphate-binding-loop of S. aureus 
MK and Rat MK, ATP and citric acid molecules are superimposed. [B] Superposition of the 
related residues from the conserved motif 2 of S. aureus MK and Rat MK in complex with ATP. 
The S. aureus MK is colored in cyan, Rat MK is shown in white. ATP and Mg molecules are 
superimposed to indicate the proposed binding site. The residues at similar positions are labeled 
in the order of Rat MK/S. aureus MK. Single letter code of amino acid is used for concision.  
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A water-mediated network is formed around the citric acid molecule. Water molecules 
W1 and W2 interact with the C1 hydroxyls of citric acid and residues His19 and 
Ala20 from conserved motif I by hydrogen bonds. Motif I in S. aureus MK/citric acid 
complex structure occupies the predicted mevalonate binding site, and conformational 
change would be required to bind mevalonate.  
 
This suggests that the conformation of structure elements between β1 and β2 may be 
flexible, These multiple interactions (mainly hydrogen bonds) between water 
molecules and residues “drag” motif I towards to the phosphate-binding-loop (motif II) 
and induce a conformational change of motif I and motif III in S. aureus MK, The 
conformational change of the loop between β6 and β7 would be achieved by the 
movement of motif I.  
 
In L. major MK/mevalonate complex structure, residues Lys18, Ile20, Glu24, His25 
and Val27 from conserved motif I and Ser152, Tyr167, Arg169, Thr195 and Val202 
interact with the mevalonate with a water-mediated network. These residues are 
highly conserved and matching Lys12, Ile14, Glu18, His19 Val21, Ser142, Phe157, 
Gln159, Thr179 and Val190 in S. aureus MK. There are two residues, Phe157 and 
Gln159 in S. aureus MK, and Tyr167 and Arg169 in L. major MK, that might have 
similar interactions with mevalonate. The changes are relatively conservative 
preserving aromatic and amino groups (hydrogen bond donor).  
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FIGURE 4.35: Stereo view of the predicted MEV binding site of S. aureus MK and L.major MK.  
S. aureus MK is shown in blue, L.major MK in grey color. The citric acid (green) and the 
mevalonate (yellow) are superimposed to indicate the predicted ATP and mevalonate binding site, 
respectively. 
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4.4.3 Mechanistic implications of S. aureus MK 
Despite the crystal structure conformation of the “adenosine strap loop”, the enzyme 
still shows normal activity, indicating the conformation we see is an artifact of 
packing. The apparent Km of S. aureus MK for mevalonate was approximately 
111.3(±6.1) µM. This value is comparable to other enzymes.  
 
Source Km for Mevalonate (mM) citations 
Pig liver 0.019 (Beytia, Dorsey et al. 1970) 
Rat liver 0.271 (Tanaka, Lee et al. 1990) 
Human liver 0.074 (Popjak 1969) 
E. faecalis 0.33 (Hedl, Rodwell al. 2003) 
M. jannaschii 0.068 (Huang, Scott et al. 1999) 
S. aureus (other strain) 0.041 (Voynova, Rios et al. 2004) 
S. aureus (this study) 0.111  
TABLE 4.7: Km for S. aureus MK and other MKs.  
 
  193 
There are four strictly conserved residues at the catalytic centre that have been 
identified to be critical for the reaction, (Lys12, Ser102, Glu134 and Asp 145 in S. 
aureus MK). Ser102 and Glu134 from motif II is considered as the key elements 
interact with the phosphate donor and Mg ion (Cho, Rios et al. 2001).  The position 
of Lys/Asp is almost identical in MKs from S. aureus, L. major, M. jannaschii and 
human. In mutational studies of human MK, the mutants Asp145Ala and Asp145Asn 
did not show any significant activity. Whist the mutant Lys12Met resulted in an 
almost 80-fold decrease of Vmax (Potter, Wojnar et al. 1997). This indicates that the 
residues Lys12 and Asp145 are very important residues of the catalytic mechanism.  
 
FIGURE 4.36: Selected sequences that strictly conserved in MKs. Identical residues in the 
sequences aligned are highlight in black. The four red boxes indicate the strictly conserved 
sequences in MKs. This alignment was generated with BioEdit program. 
In the phosphorylation reaction, the Asp145 is likely to act as the essential catalytic 
base (acceptor) with its hydroxyl group in position to attract the proton from C5 
hydroxyl group of mevalonate and generate a potent nuleophilie. Lys12 is thought to 
be responsible for fixing the orientation of the C5 hydroxyl group and also stabilizing 
the transition state (Chu and Li 2003). Ser146 may also provide some stabilizing 
effect of the transition state. Such arrangement is also observed in some other kinases 
such as Escherichia coli phosphofructokinase and Trypanosoma brucei 
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phosphoglycerate Kinase (Bossemeyer 1994; Matte, Tari et al. 1998). The residues 
from conserved motif III might have a water-mediated interaction with the 
magnesium ion and neutralize and stabilize the environment of the reaction. This 
potential catalytic mechanism is consistent with the Miziorko Lab model (Cho, Rios 
et al. 2001).  
 
FIGURE 4.37: Stereo view of the proposed catalytic centre for S. aureus MK. Protein C atoms 
are shown in marine blue, C atoms of F1P are shown in green. N atoms, O and P atoms are shown 
in blue, red and orange, respectively. Magnesium ion is shown as grey sphere. MEV, ATP and the 
two key residues Asp145 and Lys12 are shown to indicate the potential interactions with the 
hydroxyl and phosphate group.  
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FIGURE 4.38: The possible mechanism of S. aureus MK.  
4.4.4 Future work  
It is important to obtain structures for both mevalonate and AMP-PNP in the active 
site of crystal. The problem is the citrate binding which appears to lock the structure 
into a non-binding mode. Validations of the results of thermofluor assay, 
co-crystallization soaking with potential hits in library is also necessary. New 
compounds could then be synthesized to inhibit the enzyme activities.  
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